UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________________________________ 
FORM 10-Q
______________________________________ 
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2020March 31, 2021
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to

Commission File Number: 000-32191
______________________________________ 
T. ROWE PRICE GROUP, INC.
(Exact name of registrant as specified in its charter)
Maryland52-2264646
(State of incorporation)(I.R.S. Employer Identification No.)
100 East Pratt Street,, Baltimore,, Maryland21202
(Address, including Zip Code, of principal executive offices)
(410) (410) 345-2000
(Registrant’s telephone number, including area code)
________________
Common stock, $.20 par value per shareTROWThe NASDAQ Stock Market LLC
(title of security)(ticker symbol)(Name of exchange on which registered)
______________________
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 of the Securities Exchange Act of 1934 during the preceding 12 months, and (2) has been subject to such filing requirements for the past 90 days.      Yes      No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months.      Yes      No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filerAccelerated filer 
Non-accelerated filer (do not check if smaller reporting company)Smaller reporting company 
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes      No
The number of shares outstanding of the issuer’s common stock ($.20 par value), as of the latest practicable date, July
April 27, 2020,2021, is 226,985,631.226,855,575.
The exhibit index is at Item 6 on page 41.
34.






PART I – FINANCIAL INFORMATION

Item 1.Financial Statements.

Item 1. Financial Statements.

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS
(in millions, except share data)
 
3/31/202112/31/2020
ASSETS
Cash and cash equivalents$2,830.1 $2,151.7 
Accounts receivable and accrued revenue885.9 863.1 
Investments3,403.6 3,250.8 
Assets of consolidated T. Rowe Price investment products ($1,782.9 million at March 31, 2021 and $2,497.4 million at December 31, 2020, related to variable interest entities)1,946.8 2,695.5 
Operating lease assets110.2 117.6 
Property and equipment, net703.9 695.4 
Goodwill665.7 665.7 
Other assets218.2 219.2 
Total assets$10,764.4 $10,659.0 
LIABILITIES
Accounts payable and accrued expenses$228.9 $187.7 
Liabilities of consolidated T. Rowe Price investment products ($49.0 million at March 31, 2021 and $47.7 million at December 31, 2020, related to variable interest entities)53.7 57.7 
Operating lease liabilities146.0 154.1 
Accrued compensation and related costs260.8 133.6 
Supplemental savings plan liability769.9 772.2 
Income taxes payable284.0 85.0 
Total liabilities1,743.3 1,390.3 
Commitments and contingent liabilities00
Redeemable non-controlling interests1,012.9 1,561.7 
STOCKHOLDERS’ EQUITY
Preferred stock, undesignated, $.20 par value – authorized and unissued 20,000,000 shares
Common stock, $.20 par value—authorized 750,000,000; issued 226,948,000 shares at March 31, 2021 and 227,965,000 at December 31, 202045.4 45.6 
Additional capital in excess of par value654.6 654.6 
Retained earnings7,338.7 7,029.8 
Accumulated other comprehensive loss(30.5)(23.0)
Total permanent stockholders’ equity8,008.2 7,707.0 
Total liabilities, redeemable non-controlling interests, and permanent stockholders’ equity$10,764.4 $10,659.0 
The accompanying notes are an integral part of these statements.
Page 2
  6/30/2020 12/31/2019
ASSETS    
Cash and cash equivalents $2,058.1
 $1,781.8
Accounts receivable and accrued revenue 655.7
 646.6
Investments 2,900.0
 2,939.8
Assets of consolidated T. Rowe Price investment products ($2,005.4 million at June 30, 2020 and $1,975.3 million at December 31, 2019, related to variable interest entities) 2,161.5
 2,276.9
Operating lease assets 131.5
 110.8
Property and equipment, net 685.4
 674.4
Goodwill 665.7
 665.7
Other assets 219.4
 234.4
Total assets $9,477.3
 $9,330.4
     
LIABILITIES    
Accounts payable and accrued expenses $194.3
 $214.5
Liabilities of consolidated T. Rowe Price investment products ($41.6 million at June 30, 2020 and $27.0 million at December 31, 2019, related to variable interest entities) 54.8
 39.2
Operating lease liabilities 166.4
 146.3
Accrued compensation and related costs 384.7
 112.1
Supplemental savings plan liability 577.0
 563.4
Income taxes payable 259.3
 31.8
Total liabilities 1,636.5
 1,107.3
     
Commitments and contingent liabilities 


 


     
Redeemable non-controlling interests 1,090.1
 1,121.0
     
STOCKHOLDERS’ EQUITY    
Preferred stock, undesignated, $.20 par value – authorized and unissued 20,000,000 shares 
 
Common stock, $.20 par value—authorized 750,000,000; issued 226,990,000 shares at June 30, 2020 and 235,214,000 at December 31, 2019 45.4
 47.0
Additional capital in excess of par value 654.6
 654.6
Retained earnings 6,102.9
 6,443.5
Accumulated other comprehensive loss (52.2) (43.0)
Total permanent stockholders’ equity 6,750.7
 7,102.1
Total liabilities, redeemable non-controlling interests, and permanent stockholders’ equity $9,477.3
 $9,330.4



UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(in millions, except per-share amounts)
 
 Three months ended
 3/31/20213/31/2020
Revenues
Investment advisory fees$1,687.8 $1,327.8 
Administrative, distribution, and servicing fees139.0 134.8 
Net revenues1,826.8 1,462.6 
Operating expenses
Compensation and related costs583.5 440.7 
Distribution and servicing85.6 65.7 
Advertising and promotion18.9 24.9 
Product-related costs41.0 41.6 
Technology, occupancy, and facility costs117.3 105.4 
General, administrative, and other87.3 77.1 
Total operating expenses933.6 755.4 
Net operating income893.2 707.2 
Non-operating income (loss)
Net gains (losses) on investments68.6 (154.6)
Net gains (losses) on consolidated investment products37.2 (330.3)
Other income (loss)(3.7)(15.4)
Total non-operating income (loss)102.1 (500.3)
Income before income taxes995.3 206.9 
Provision for income taxes230.5 40.3 
Net income764.8 166.6 
Less: net income (loss) attributable to redeemable non-controlling interests15.4 (176.5)
Net income attributable to T. Rowe Price Group$749.4 $343.1 
Earnings per share on common stock of T. Rowe Price Group
Basic$3.20 $1.43 
Diluted$3.17 $1.41 

The accompanying notes are an integral part of these statements.
Page 3
 Three months ended Six months ended
 6/30/2020 6/30/2019 6/30/2020 6/30/2019
Revenues       
Investment advisory fees$1,293.8
 $1,270.2
 $2,621.6
 $2,464.4
Administrative, distribution, and servicing fees121.6
 125.0
 256.4
 258.1
Net revenues1,415.4
 1,395.2
 2,878.0
 2,722.5
        
Operating expenses       
Compensation and related costs549.0
 483.2
 989.7
 974.7
Distribution and servicing62.0
 64.4
 127.7
 130.8
Advertising and promotion13.4
 19.8
 38.3
 41.4
Product-related costs39.6
 33.4
 81.2
 77.6
Technology, occupancy, and facility costs111.3
 104.9
 216.7
 203.0
General, administrative, and other86.4
 74.4
 163.5
 147.4
Total operating expenses861.7
 780.1
 1,617.1
 1,574.9
        
Net operating income553.7
 615.1
 1,260.9
 1,147.6
        
Non-operating income (loss)       
Net gains on investments170.6
 61.8
 16.0
 161.9
Net gains (losses) on consolidated investment products242.5
 62.8
 (87.8) 164.7
Other income (loss)2.0
 (.1) (13.4) .7
Total non-operating income (loss)415.1
 124.5
 (85.2) 327.3
        
Income before income taxes968.8
 739.6
 1,175.7
 1,474.9
Provision for income taxes240.3
 183.7
 280.6
 365.0
Net income728.5
 555.9
 895.1
 1,109.9
Less: net income (loss) attributable to redeemable non-controlling interests125.5
 28.4
 (51.0) 69.8
Net income attributable to T. Rowe Price Group$603.0
 $527.5
 $946.1
 $1,040.1
        
Earnings per share on common stock of T. Rowe Price Group      
Basic$2.58
 $2.18
 $3.99
 $4.29
Diluted$2.55
 $2.15
 $3.95
 $4.23




UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(in millions)
 
 Three months ended
 3/31/20213/31/2020
Net income$764.8 $166.6 
Other comprehensive income (loss)
Currency translation adjustments
Consolidated T. Rowe Price investment products - variable interest entities(18.9)(25.1)
Reclassification gains recognized in non-operating income upon deconsolidation of certain T. Rowe Price investment products(2.6)(.1)
Total currency translation adjustments of consolidated T. Rowe Price investment products - variable interest entities(21.5)(25.2)
Equity method investments(.8)(.1)
Other comprehensive loss before income taxes(22.3)(25.3)
Net deferred tax benefits3.0 2.0 
Total other comprehensive loss(19.3)(23.3)
Total comprehensive income745.5 143.3 
Less: comprehensive income (loss) attributable to redeemable non-controlling interests3.6 (193.7)
Total comprehensive income attributable to T. Rowe Price Group$741.9 $337.0 

The accompanying notes are an integral part of these statements.
Page 4
 Three months ended Six months ended
 6/30/2020 6/30/2019 6/30/2020 6/30/2019
Net income$728.5
 $555.9
 $895.1
 $1,109.9
Other comprehensive income (loss)       
Currency translation adjustments       
Consolidated T. Rowe Price investment products - variable interest entities15.9
 3.7
 (9.2) (2.1)
Reclassification gains recognized in non-operating income upon deconsolidation of certain T. Rowe Price investment products
 (.1) (.1) (.2)
Total currency translation adjustments of consolidated T. Rowe Price investment products - variable interest entities15.9
 3.6
 (9.3) (2.3)
Equity method investments(9.4) 1.5
 (9.5) 6.4
Other comprehensive income (loss) before income taxes6.5
 5.1
 (18.8) 4.1
Net deferred tax benefits.7
 (1.0) 2.7
 (.9)
Total other comprehensive income (loss)7.2
 4.1
 (16.1) 3.2
        
Total comprehensive income735.7
 560.0
 879.0
 1,113.1
Less: comprehensive income (loss) attributable to redeemable non-controlling interests135.8
 29.4
 (57.9) 69.5
Total comprehensive income attributable to T. Rowe Price Group$599.9
 $530.6
 $936.9
 $1,043.6




UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in millions)
Six months ended Three months ended
6/30/2020 6/30/2019 3/31/20213/31/2020
Cash flows from operating activities   Cash flows from operating activities
Net income$895.1
 $1,109.9
Net income$764.8 $166.6 
Adjustments to reconcile net income to net cash provided by operating activities   Adjustments to reconcile net income to net cash provided by operating activities
Depreciation and amortization of property and equipment94.3
 86.0
Depreciation and amortization of property and equipment49.0 46.1 
Stock-based compensation expense111.6
 90.7
Stock-based compensation expense57.5 58.3 
Net (gains) losses recognized on investments3.4
 (124.4)Net (gains) losses recognized on investments(59.5)167.3 
Net investments in T. Rowe Price investment products used to economically hedge supplemental savings plan liability(10.0) (19.3)
Net change in T. Rowe Price investment products used to economically hedge supplemental savings plan liabilityNet change in T. Rowe Price investment products used to economically hedge supplemental savings plan liability22.0 (8.9)
Net change in securities held by consolidated T. Rowe Price investment products40.8
 (444.0)Net change in securities held by consolidated T. Rowe Price investment products(120.9)234.6 
Other changes in assets and liabilities505.5
 249.9
Other changes in assets and liabilities281.8 123.7 
Net cash provided by operating activities1,640.7
 948.8
Net cash provided by operating activities994.7 787.7 
   
Cash flows from investing activities   Cash flows from investing activities
Purchases of T. Rowe Price investment products(237.1) (34.9)Purchases of T. Rowe Price investment products(12.5)(225.1)
Dispositions of T. Rowe Price investment products347.9
 103.8
Dispositions of T. Rowe Price investment products60.3 299.1 
Net cash of T. Rowe Price investment products on deconsolidation(9.2) (5.1)Net cash of T. Rowe Price investment products on deconsolidation(27.3)(.8)
Additions to property and equipment(105.3) (94.5)Additions to property and equipment(58.8)(46.0)
Other investing activity6.1
 1.6
Other investing activity7.5 .4 
Net cash provided by (used in) investing activities2.4
 (29.1)
Net cash (used in) provided by investing activitiesNet cash (used in) provided by investing activities(30.8)27.6 
   
Cash flows from financing activities   Cash flows from financing activities
Repurchases of common stock(1,027.1) (402.8)Repurchases of common stock(259.2)(891.3)
Common share issuances under stock-based compensation plans54.0
 78.8
Common share issuances under stock-based compensation plans20.9 38.1 
Dividends paid to common stockholders of T. Rowe Price Group(425.7) (367.8)Dividends paid to common stockholders of T. Rowe Price Group(252.3)(215.2)
Net subscriptions received from redeemable non-controlling interest holders87.7
 190.3
Net subscriptions received from redeemable non-controlling interest holders183.1 76.1 
Net cash used in financing activities(1,311.1) (501.5)Net cash used in financing activities(307.5)(992.3)
   
Effect of exchange rate changes on cash and cash equivalents of consolidated
T. Rowe Price investment products
(7.4) (.4)
Effect of exchange rate changes on cash and cash equivalents of consolidated
T. Rowe Price investment products
.9 (1.2)
   
Net change in cash and cash equivalents during period324.6
 417.8
Net change in cash and cash equivalents during period657.3 (178.2)
Cash and cash equivalents at beginning of period, including $76.5 million at December 31, 2019, and $70.1 million at December 31, 2018, held by consolidated T. Rowe Price investment products1,858.3
 1,495.3
Cash and cash equivalents at end of period, including $124.8 million at June 30, 2020, and $110.7 million at June 30, 2019, held by consolidated T. Rowe Price investment products$2,182.9
 $1,913.1
Cash and cash equivalents at beginning of period, including $104.8 million at December 31, 2020, and $76.5 million at December 31, 2019, held by consolidated T. Rowe Price investment productsCash and cash equivalents at beginning of period, including $104.8 million at December 31, 2020, and $76.5 million at December 31, 2019, held by consolidated T. Rowe Price investment products2,256.5 1,858.3 
Cash and cash equivalents at end of period, including $83.7 million at March 31, 2021, and $117.7 million at March 31, 2020, held by consolidated T. Rowe Price investment productsCash and cash equivalents at end of period, including $83.7 million at March 31, 2021, and $117.7 million at March 31, 2020, held by consolidated T. Rowe Price investment products$2,913.8 $1,680.1 


The accompanying notes are an integral part of these statements.
Page 5



UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(shares in thousands; dollars in millions)
 Three months ended 6/30/2020
 Common
shares
outstanding
 Common
stock
 Additional
capital in
excess of
par value
 Retained
earnings
 
AOCI(1)
 Total
stockholders’
equity
 Redeemable non-controlling interests
Balances at March 31, 2020227,985
 $45.6
 $654.6
 $5,782.9
 $(49.1) $6,434.0
 971.0
Net income
 
 
 603.0
 
 603.0
 125.5
Other comprehensive loss, net of tax
 
 
 
 (3.1) (3.1) 10.3
Dividends declared ($0.90 per share)
 
 
 (210.3) 
 (210.3) 
Shares issued upon option exercises296
 .1
 15.8
 
 
 15.9
 
Restricted shares issued, net of shares withheld for taxes8
 
 
 
 
 
 
Net shares issued upon vesting of restricted stock units6
 
 (.3) 
 
 (.3) 
Stock-based compensation expense
 
 53.3
 
 
 53.3
 
Restricted stock units issued as dividend equivalents
 
 .1
 (.1) 
 
 
Common shares repurchased(1,305) (.3) (68.9) (72.6) 
 (141.8) 
Net subscriptions into T. Rowe Price investment products
 
 
 
 
 
 26.1
Net deconsolidations of T. Rowe Price investment products
 
 
 
 
 
 (42.8)
Balances at June 30, 2020226,990
 $45.4
 $654.6
 $6,102.9
 $(52.2) $6,750.7
 $1,090.1
              
 Three months ended 6/30/2019
 Common
shares
outstanding
 Common
stock
 Additional
capital in
excess of
par value
 Retained
earnings
 
AOCI(1)
 Total
stockholders’
equity
 Redeemable non-controlling interests
Balances at March 31, 2019236,432
 $47.3
 $654.5
 $5,650.8
 $(41.6) $6,311.0
 $886.7
Net income
 
 
 527.5
 
 527.5
 28.4
Other comprehensive income (loss), net of tax
 
 
 
 3.1
 3.1
 1.0
Dividends declared ($0.76 per share)
 
 
 (183.4) 
 (183.4) 
Shares issued upon option exercises665
 .1
 37.7
 
 
 37.8
 
Restricted shares issued, net of shares withheld for taxes7
 
 (.1) 
 
 (.1) 
Net shares issued upon vesting of restricted stock units19
 
 (.2) 
 
 (.2) 
Forfeiture of restricted awards(2) 
 
 
 
 
 
Stock-based compensation expense
 
 47.2
 
 
 47.2
 
Restricted stock units issued as dividend equivalents
 
 .1
 (.1) 
 
 
Common shares repurchased(1,603) (.3) (84.6) (78.9) 
 (163.8) 
Net subscriptions into T. Rowe Price investment products
 
 
 
 
 
 125.7
Net deconsolidations of T. Rowe Price investment products
 
 
 
 
 
 (29.5)
Balances at June 30, 2019235,518
 $47.1
 $654.6
 $5,915.9
 $(38.5) $6,579.1
 $1,012.3

Three months ended 3/31/2021
Common
shares
outstanding
Common
stock
Additional
capital in
excess of
par value
Retained
earnings
AOCI(1)
Total
stockholders’
equity
Redeemable non-controlling interests
Balances at December 31, 2020227,965 $45.6 $654.6 $7,029.8 $(23.0)$7,707.0 $1,561.7 
Net income— — — 749.4 — 749.4 15.4 
Other comprehensive income (loss), net of tax— — — — (7.5)(7.5)(11.8)
Dividends declared ($1.08 per share)— — — (252.3)— (252.3)— 
Shares issued upon option exercises572 .1 25.3 — — 25.4 — 
Net shares issued upon vesting of restricted stock units41 — (3.7)— — (3.7)— 
Stock-based compensation expense— — 57.5 — — 57.5 — 
Restricted stock units issued as dividend equivalents— — .1 (.1)— — — 
Common shares repurchased(1,630)(.3)(79.2)(188.1)— (267.6)— 
Net subscriptions into T. Rowe Price investment products— — — — — — 187.5 
Net deconsolidations of T. Rowe Price investment products— — — — — — (739.9)
Balances at March 31, 2021226,948 $45.4 $654.6 $7,338.7 $(30.5)$8,008.2 $1,012.9 
Three months ended 3/31/2020
Common
shares
outstanding
Common
stock
Additional
capital in
excess of
par value
Retained
earnings
AOCI(1)
Total
stockholders’
equity
Redeemable non-controlling interests
Balances at December 31, 2019235,214 $47.0 $654.6 $6,443.5 $(43.0)$7,102.1 $1,121.0 
Net income— — — 343.1 — 343.1 (176.5)
Other comprehensive income (loss), net of tax— — — — (6.1)(6.1)(17.2)
Dividends declared ($0.90 per share)— — — (214.7)— (214.7)— 
Shares issued upon option exercises1,068 .2 41.1 — — 41.3 — 
Net shares issued upon vesting of restricted stock units37 — (3.0)— — (3.0)— 
Stock-based compensation expense— — 58.3 — — 58.3 — 
Restricted stock units issued as dividend equivalents— — .1 (.1)— — 
Common shares repurchased(8,334)(1.6)(96.5)(788.9)— (887.0)— 
Net subscriptions into T. Rowe Price investment products— — — — — — 63.8 
Net deconsolidations of T. Rowe Price investment products— — — — — — (20.1)
Balances at March 31, 2020227,985 $45.6 $654.6 $5,782.9 $(49.1)$6,434.0 $971.0 

(1) Accumulated other comprehensive income.


The accompanying notes are an integral part of these statements.
Page 6

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(shares in thousands; dollars in millions)

 Six months ended 6/30/2020
 Common
shares
outstanding
 Common
stock
 Additional
capital in
excess of
par value
 Retained
earnings
 
AOCI(1)
 Total
stockholders’
equity
 Redeemable non-controlling interests
Balances at December 31, 2019235,214
 $47.0
 $654.6
 $6,443.5
 $(43.0) $7,102.1
 $1,121.0
Net income
 
 
 946.1
 
 946.1
 (51.0)
Other comprehensive income (loss), net of tax
 
 
 
 (9.2) (9.2) (6.9)
Dividends declared ($1.80 per share)
 
 
 (425.1) 
 (425.1) 
Shares issued upon option exercises1,364
 .3
 56.9
 
 
 57.2
 
Restricted shares issued, net of shares withheld for taxes8
 
 
 
 
 
 
Shares issued upon vesting of restricted stock units, net of shares withheld for taxes43
 
 (3.3) 
 
 (3.3) 
Stock-based compensation expense
 
 111.6
 
 
 111.6
 
Restricted stock units issued as dividend equivalents
 
 .1
 (.1) 
 
 
Common shares repurchased(9,639) (1.9) (165.3) (861.5) 
 (1,028.7) 
Net subscriptions into T. Rowe Price investment products
 
 
 
 
 
 89.9
Net deconsolidations of T. Rowe Price investment products
 
 
 
 
 
 (62.9)
Balances at June 30, 2020226,990
 $45.4
 $654.6
 $6,102.9
 $(52.2) $6,750.7
 $1,090.1
              
 Six months ended 6/30/2019
 Common
shares
outstanding
 Common
stock
 Additional
capital in
excess of
par value
 Retained
earnings
 
AOCI(1)
 Total
stockholders’
equity
 Redeemable non-controlling interests
Balances at December 31, 2018238,069
 $47.6
 $654.6
 $5,464.1
 $(42.0) $6,124.3
 $740.3
Net income
 
 
 1,040.1
 
 1,040.1
 69.8
Other comprehensive income (loss), net of tax
 
 
 
 3.5
 3.5
 (.3)
Dividends declared ($1.52 per share)
 
 
 (367.2) 
 (367.2) 
Shares issued upon option exercises1,495
 .3
 82.5
 
 
 82.8
 
Restricted shares issued, net of shares withheld for taxes7
 
 (.1) 
 
 (.1) 
Shares issued upon vesting of restricted stock units, net of shares withheld for taxes33
 
 (1.4) 
 
 (1.4) 
Forfeiture of restricted awards(7) 
 
 
 
 
 
Stock-based compensation expense
 
 90.7
 
 
 90.7
 
Restricted stock units issued as dividend equivalents
 
 .1
 (.1) 
 
 
Common shares repurchased(4,079) (.8) (171.8) (221.0) 
 (393.6) 
Net subscriptions into T. Rowe Price investment products
 
 
 
 
 
 211.6
Net deconsolidations of T. Rowe Price investment products
 
 
 
 
 
 (9.1)
Balances at June 30, 2019235,518
 $47.1
 $654.6
 $5,915.9
 $(38.5) $6,579.1
 $1,012.3
(1)Accumulated other comprehensive income.



NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1 – THE COMPANY AND BASIS OF PREPARATION.

T. Rowe Price Group Inc. derives its consolidated revenues and net income primarily from investment advisory services that its subsidiaries provide to individual and institutional investors in the T. Rowe Price U.S. mutual funds (“U.S. mutual funds”), subadvised funds, separately managed accounts, subadvised funds,collective investment trusts, and other
T. Rowe Price products. The other T. Rowe Price products include: collective investment trusts,include open-ended investment products offered to investors outside the U.S., and products offered through variable annuity life insurance plans in the U.S. We also provide certain investment advisory clients with related administrative services, including distribution, mutual fund transfer agent, accounting, and shareholder services; participant recordkeeping and transfer agent services for defined contribution retirement plans; brokerage; trust services; and trust services.non-discretionary advisory services through model delivery.

Investment advisory revenues depend largely on the total value and composition of assets under our management. Accordingly, fluctuations in financial markets and in the composition of assets under management impact our revenues and results of operations.

BASIS OF PRESENTATION.

These unaudited condensed consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States. These principles require the use of estimates and reflect all adjustments that are, in the opinion of management, necessary for a fair statement of our results for the interim periods presented. All such adjustments are of a normal recurring nature. Actual results may vary from our estimates. Certain prior year amounts have been reclassified to conform to the 20202021 presentation.

The unaudited interim financial information contained in these unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements contained in our 20192020 Annual Report.

NEW ACCOUNTING GUIDANCE.

We adopted Accounting Standards Update No. 2018-15 — Intangibles—Goodwill and Other— Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract on January 1, 2020 using the prospective method of adoption. This update required implementation costs incurred in cloud computing arrangements to be deferred and recognized over the term of the hosting arrangement. A hosting arrangement is an agreement that allows customers, like us, to access and use software on an as-needed basis without having possession of the software. Beginning on January 1, 2020, we are required to defer such qualifying implementation costs. As of June 30, 2020, we capitalized an immaterial amount of implementation costs incurred in a cloud computing arrangement. Accordingly, the adoption of this guidance did not have a material impact on our consolidated balance sheets or our consolidated statements of income.

NEWLY ISSUED BUT NOT YET ADOPTED ACCOUNTING GUIDANCE

We have considered all other newly issued accounting guidance that is applicable to our operations and the preparation of our unaudited condensed consolidated statements, including those we have not yet adopted. We do not believe that any such guidance has or will have a material effect on our financial position or results of operations.

U.S. ECONOMIC RELIEF LEGISLATION

On March 27, 2020, the U.S. enacted the Coronavirus Aid, Relief and Economic Security ("CARES") Act. The CARES Act provides economic relief to eligible businesses and individuals impacted by the novel coronavirus pandemic. The CARES Act’s provisions will not have a material impact on our financial position and results of operations.



Page 8



NOTE 2 – INFORMATION ABOUT RECEIVABLES, REVENUES, AND SERVICES.

Revenues earned during the three- and six-month periods ended June 30, 2020 and 2019 under agreements with clients include: 
Three months ended 3/31/2021Three months ended 3/31/2020
Administrative, distribution, and servicing feesAdministrative, distribution, and servicing fees
(in millions)Investment advisory feesAdministrative feesDistribution and servicing feesNet revenuesInvestment advisory feesAdministrative feesDistribution and servicing feesNet revenues
U.S. mutual funds$1,050.2 $78.7 $29.1 $1,158.0 $876.2 $77.2 $27.9 $981.3 
Subadvised funds, separate accounts, collective investment trusts, and other investment products637.6 637.6 451.6 451.6 
Other clients(1)
31.2 31.2 29.7 29.7 
$1,687.8 $109.9 $29.1 $1,826.8 $1,327.8 $106.9 $27.9 $1,462.6 
 Three months ended 6/30/2020 Three months ended 6/30/2019
   Administrative, distribution, and servicing fees     Administrative, distribution, and servicing fees  
(in millions)Investment advisory fees Administrative fees Distribution and servicing fees Net revenues Investment advisory fees Administrative fees Distribution and servicing fees Net revenues
U.S. mutual funds$823.1
 $69.4
 $25.7
 $918.2
 $860.7
 $69.7
 $30.1
 $960.5
Subadvised and separate accounts and other investment products470.7
 
 
 470.7
 409.5
 
 
 409.5
Other clients
 26.5
 
 26.5
 
 25.2
 
 25.2
 $1,293.8
 $95.9
 $25.7
 $1,415.4
 $1,270.2
 $94.9
 $30.1
 $1,395.2
                
 Six months ended 6/30/2020 Six months ended 6/30/2019
   Administrative, distribution, and servicing fees     Administrative, distribution, and servicing fees  
(in millions)Investment advisory fees Administrative fees Distribution and servicing fees Net revenues Investment advisory fees Administrative fees Distribution and servicing fees Net revenues
U.S. mutual funds$1,699.3
 $146.6
 $53.6
 $1,899.5
 $1,676.6
 $146.3
 $60.3
 $1,883.2
Subadvised and separate accounts and other investment products922.3
 
 
 922.3
 787.8
 
 
 787.8
Other clients
 56.2
 
 56.2
 
 51.5
 
 51.5
 $2,621.6
 $202.8
 $53.6
 $2,878.0
 $2,464.4
 $197.8
 $60.3
 $2,722.5

(1) Other clients primarily include individuals, defined contribution plans, college savings plans, and institutions related to model delivery.

Total net revenues earned from our related parties, specifically T. Rowe Price investment products, aggregate $1,142.8$1,482.3 million and $1,147.6$1,207.7 million for the three months ended June 30,March 31, 2021 and 2020, and 2019, respectively. Total net revenues earned during the six months ended June 30, 2020 and 2019 aggregate $2,350.5 million and $2,241.0 million, respectively. Accounts

Page 7


receivable from these products aggregate to $410.6$540.0 million at June 30, 2020,March 31, 2021, and $424.8$523.4 million at December 31, 2019.2020.

Following a change toIn the second quarter of 2020, we changed our fee structure of the target date retirement funds insuch that our investment advisory fee revenue is now earned at the second quarter of 2020,target date retirement fund level rather than at the underlying mutual fund level. As a result, we have modified our investment advisory fee and assets under management presentation below to separately breakout the fees earned from clients and related assets under management of our multi-asset portfolios. All prior periods have been recast to conform to this new presentation and to provide comparability.


Page 9



The following table details the investment advisory fees earned from clients by their underlying asset class.
Three months ended Six months ended Three months ended
(in millions)6/30/2020 6/30/2019 6/30/2020 6/30/2019(in millions)3/31/20213/31/2020
U.S. mutual funds       U.S. mutual funds
Equity$545.9
 $553.8
 $1,114.3
 $1,071.2
Equity$729.8 $568.4 
Fixed income, including money market66.8
 69.1
 138.5
 137.9
Fixed income, including money market59.0 71.7 
Multi-asset210.4
 237.8
 446.5
 467.5
Multi-asset261.4 236.1 
823.1
 860.7
 1,699.3
 1,676.6
1,050.2 876.2 
Subadvised and separate accounts and other investment products       
Subadvised funds, separate accounts, collective investment trusts, and other investment productsSubadvised funds, separate accounts, collective investment trusts, and other investment products
Equity305.6
 255.0
 585.1
 491.5
Equity429.8 279.5 
Fixed income, including money market33.9
 39.0
 71.9
 76.3
Fixed income, including money market31.7 38.0 
Multi-asset131.2
 115.5
 265.3
 220.0
Multi-asset176.1 134.1 
470.7
 409.5
 922.3
 787.8
637.6 451.6 
Total$1,293.8
 $1,270.2
 $2,621.6
 $2,464.4
Total$1,687.8 $1,327.8 


The following table summarizes the assets under management on which we earn investment advisory fees.
Average during Average during  Average during
Three months ended Six months ended As ofThree months endedAs of
(in billions)6/30/2020 6/30/2019 6/30/2020 6/30/2019 6/30/2020 12/31/2019(in billions)3/31/20213/31/20203/31/202112/31/2020
U.S. mutual funds           U.S. mutual funds
Equity$374.5
 $375.8
 $381.4
 $365.1
 $407.3
 $407.1
Equity$509.6 $388.3 $511.7 $498.6 
Fixed income, including money market74.2
 70.8
 75.0
 70.3
 75.3
 73.7
Fixed income, including money market82.3 75.7 82.6 79.4 
Multi-asset179.9
 191.9
 185.1
 189.0
 188.2
 201.9
Multi-asset222.6 190.3 222.1 216.6 
628.6
 638.5
 641.5
 624.4
 670.8
 682.7
814.5 654.3 816.4 794.6 
Subadvised and separate accounts and other investment products           
Subadvised funds, separate accounts, collective investment trusts, and other investment productsSubadvised funds, separate accounts, collective investment trusts, and other investment products
Equity293.2
 254.1
 285.3
 245.5
 311.6
 291.7
Equity418.9 277.5 405.5 397.2 
Fixed income, including money market77.1
 78.6
 79.2
 77.9
 77.7
 74.2
Fixed income, including money market80.2 81.3 90.2 89.3 
Multi-asset141.3
 128.6
 145.4
 124.0
 159.9
 158.2
Multi-asset195.2 149.6 205.9 189.4 
511.6
 461.3
 509.9
 447.4
 549.2
 524.1
694.3 508.4 701.6 675.9 
Total$1,140.2
 $1,099.8
 $1,151.4
 $1,071.8
 $1,220.0
 $1,206.8
Total$1,508.8 $1,162.7 $1,518.0 $1,470.5 


Investors that we serve are primarily domiciled in the U.S.; investment advisory clients outside the U.S. account for 8.2%8.8% and 6.9%9.3% of our assets under management at June 30, 2020,March 31, 2021, and December 31, 2019,2020, respectively.



Page 108




NOTE 3 – INVESTMENTS.

The carrying values of our investments that are not part of the consolidated T. Rowe Price investment products are as follows:
(in millions)3/31/202112/31/2020
Investments held at fair value
T. Rowe Price investment products
Discretionary investments$1,664.3 $1,647.7 
Seed capital269.5 169.5 
Supplemental savings plan liability economic hedges766.9 768.1 
Investment partnerships and other investments100.6 95.1 
Equity method investments
T. Rowe Price investment products
Discretionary investments245.8 242.9 
Seed capital203.7 178.6 
23% investment in UTI Asset Management Company Limited (India)149.1 145.5 
Investment partnerships and other investments2.7 2.4 
U.S. Treasury note1.0 1.0 
Total$3,403.6 $3,250.8 
(in millions)6/30/2020 12/31/2019
Investments held at fair value   
T. Rowe Price investment products - discretionary investments$992.4
 $1,221.8
T. Rowe Price investment products - seed capital132.2
 181.1
T. Rowe Price investment products - supplemental savings plan liability economic hedges529.2
 561.1
Investment partnerships and other investments93.4
 99.7
Equity method investments   
T. Rowe Price investment products - discretionary investments809.6
 610.0
T. Rowe Price investment products - seed capital145.3
 95.6
T. Rowe Price investment products - supplemental savings plan liability economic hedges35.3
 
26% interest in UTI Asset Management Company Limited (India)155.9
 164.5
Investment partnerships and other investments5.7
 5.0
U.S. Treasury note1.0
 1.0
Total$2,900.0
 $2,939.8

The investment partnerships are carried at fair value using net asset value (“NAV”) per share as a practical expedient. Our interests in these partnerships are generally not redeemable and are subject to significant restrictions on transferability.transferability restrictions. The underlying investments of these partnerships have contractual terms through 2029, though we may receive distributions of liquidating assets over a longer term. The investment strategies of these partnerships include growth equity, buyout, venture capital, and real estate.

During the three- and six-three months ended June 30, 2020,March 31, 2021, net gains on investments included $125.5$38.8 million and $21.9 million, respectively, of net unrealized gains related to investments held at fair value that were still held at June 30, 2020.March 31, 2021. For the same period of 2019, the2020, net gainslosses on investments included $28.7$103.6 million and $79.3 million, respectively, of net unrealized gains onlosses related to investments held at fair value that were still held at June 30, 2019.March 31, 2020.

During the sixthree months ended June 30,March 31, 2021 and 2020, and 2019, certain T. Rowe Price investment products in which we provided initial seed capital at the time of formation were deconsolidated, as we no longer had a controlling interest. Depending on our ownership interest, we are now reporting our residual interests in these T. Rowe Price investment products as either an equity method investment or an investment held at fair value. Additionally, during the sixthree months ended 2019,March 31, 2020, certain T. Rowe Price investment products that were being accounted for as equity method investments were consolidated, as we regained a controlling interest. The net impact of these changes on our unaudited condensed consolidated balance sheets and statements of income as of the dates the portfolios were deconsolidated or reconsolidated is detailed below.
Three months ended
(in millions)3/31/20213/31/2020
Net decrease in assets of consolidated T. Rowe Price investment products$(928.1)$(46.2)
Net decrease in liabilities of consolidated T. Rowe Price investment products$(15.3)$(2.4)
Net decrease in redeemable non-controlling interests$(739.9)$(20.1)
Gains recognized upon deconsolidation$2.6 $.1 
 Three months ended Six months ended
(in millions)6/30/2020 6/30/2019 6/30/2020 6/30/2019
Net increase (decrease) in assets of consolidated T. Rowe Price investment products$(100.0) $(68.4) $(146.2) $(56.1)
Net decrease in liabilities of consolidated T. Rowe Price investment products$(1.2) $(.3) $(3.6) $(1.2)
Net increase (decrease) in redeemable non-controlling interests$(42.8) $(29.5) $(62.9) $(9.1)
        
Gains recognized upon deconsolidation$
 $.1
 $.1
 $.2



Page 11



The gains or losses recognized upon deconsolidation were the result of reclassifying currency translation adjustments accumulated on certain T. Rowe Price investment products with non-USD functional currencies from accumulated other comprehensive income to non-operating income (loss).income.




Page 9


VARIABLE INTEREST ENTITIES.

Our investments at June 30, 2020March 31, 2021 and December 31, 2019,2020, include interests in variable interest entities that we do not consolidate as we are not deemed the primary beneficiary. Our maximum risk of loss related to our involvement with these entities is as follows:
(in millions)3/31/202112/31/2020
Investment carrying values$289.6 $144.7 
Unfunded capital commitments11.3 12.3 
Accounts receivable60.7 13.8 
$361.6 $170.8 
(in millions)6/30/2020 12/31/2019
Investment carrying values$112.5
 $156.0
Unfunded capital commitments14.4
 18.1
Uncollected investment advisory and administrative fees8.1
 10.5
 $135.0
 $184.6


The unfunded capital commitments totaling $14.4$11.3 million at June 30, 2020,March 31, 2021 and $18.1$12.3 million at December 31, 2019,2020 relate primarily to the investment partnerships in which we have an existing investment. In addition to such amounts, a percentage of prior distributions may be called under certain circumstances.

NOTE 4 – FAIR VALUE MEASUREMENTS.

We determine the fair value of our cash equivalents and investments held at fair value using the following broad levels of inputs as defined by related accounting standards:

Level 1 – quoted prices in active markets for identical securities.
Level 2 – observable inputs other than Level 1 quoted prices including, but not limited to, quoted prices for similar
securities, interest rates, prepayment speeds, and credit risk. These inputs are based on market data
     securities, interest rates, prepayment speeds, and credit risk. These inputs are based on market data
obtained from independent sources.
Level 3 – unobservable inputs reflecting our own assumptions based on the best information available. We do not
value any investments using Level 3 inputs.

These levels are not necessarily an indication of the risk or liquidity associated with our investments. The following table summarizes our investments that are recognized in our unaudited condensed consolidated balance sheets using fair value measurements determined based on the differing levels of inputs. This table excludes investments held by the consolidated T. Rowe Price investment products which are presented separately on our unaudited condensed consolidated balance sheets and are detailed in Note 5.

 6/30/2020 12/31/2019
(in millions)Level 1 Level 2 Level 1 Level 2
Cash equivalents held in T. Rowe Price money market funds$1,705.1
 $
 $1,355.6
 $
T. Rowe Price investment products - discretionary investments992.4
 
 1,221.8
 
T. Rowe Price investment products - seed capital122.3
 9.9
 171.2
 9.9
T. Rowe Price investment products - supplemental savings plan liability economic hedges529.2
 
 561.1
 
Other investments.2
 2.7
 
 
Total$3,349.2
 $12.6
 $3,309.7
 $9.9
3/31/202112/31/2020
(in millions)Level 1Level 2Level 1Level 2
T. Rowe Price investment products
Cash equivalents held in money market funds2,487.5 $— $1,931.1 $— 
Discretionary investments1,664.3 — 1,647.7 — 
Seed capital254.6 14.9 156.6 12.9 
Supplemental savings plan liability economic hedges766.9 768.1 — 
Other investments.2 .7 .5 .6 
Total$5,173.5 $15.6 $4,504.0 $13.5 

As required by the accounting guidance, theThe fair value hierarchy level table above does not include the investment partnerships and other investments for which fair value is estimated using their NAV per share as a practical expedient. The carrying value of these investments as disclosed in Note 3 were $90.5$99.7 million at June 30, 2020,March 31, 2021, and $99.7$94.0 million at December 31, 2019.2020.




Page 12



NOTE 5 – CONSOLIDATED T. ROWE PRICE INVESTMENT PRODUCTS.

The T. Rowe Price investment products that we consolidate in our unaudited condensed consolidated financial statements are generally those products we provided initial seed capital at the time of their formation and have a controlling interest. Our U.S. mutual funds are considered voting interest entities, while those regulated outside the U.S. are considered variable interest entities.

Page 10


The following table details the net assets of the consolidated T. Rowe Price investment products:
 6/30/2020 12/31/2019
(in millions)Voting
interest entities
 Variable interest entities Total Voting
interest entities
 Variable interest entities Total
Cash and cash equivalents(1)
$11.4
 $113.4
 $124.8
 $9.9
 $66.6
 $76.5
Investments(2)
138.0
 1,865.8
 2,003.8
 281.1
 1,891.3
 2,172.4
Other assets6.7
 26.2
 32.9
 10.6
 17.4
 28.0
Total assets156.1
 2,005.4
 2,161.5
 301.6
 1,975.3
 2,276.9
Liabilities13.2
 41.6
 54.8
 12.2
 27.0
 39.2
Net assets$142.9
 $1,963.8
 $2,106.7
 $289.4
 $1,948.3
 $2,237.7
            
Attributable to T. Rowe Price Group$111.4
 $905.2
 $1,016.6
 $199.6
 $917.1
 $1,116.7
Attributable to redeemable non-controlling interests31.5
 1,058.6
 1,090.1
 89.8
 1,031.2
 1,121.0
 $142.9
 $1,963.8
 $2,106.7
 $289.4
 $1,948.3
 $2,237.7

3/31/202112/31/2020
(in millions)Voting
interest entities
Variable interest entitiesTotalVoting
interest entities
Variable interest entitiesTotal
Cash and cash equivalents(1)
$3.0 $80.7 $83.7 $7.1 $97.7 $104.8 
Investments(2)
157.5 1,664.5 1,822.0 188.2 2,372.7 2,560.9 
Other assets3.4 37.7 41.1 2.8 27.0 29.8 
Total assets163.9 1,782.9 1,946.8 198.1 2,497.4 2,695.5 
Liabilities4.7 49.0 53.7 10.0 47.7 57.7 
Net assets$159.2 $1,733.9 $1,893.1 $188.1 $2,449.7 $2,637.8 
Attributable to T. Rowe Price Group$96.4 $783.8 $880.2 $130.7 $945.4 $1,076.1 
Attributable to redeemable non-controlling interests62.8 950.1 1,012.9 57.4 1,504.3 1,561.7 
$159.2 $1,733.9 $1,893.1 $188.1 $2,449.7 $2,637.8 
(1) Cash and cash equivalents includes $10.5$2.8 million at June 30, 2020,March 31, 2021, and $9.1$7.0 million at December 31, 2019,2020, of T. Rowe Price money market mutual funds.
(2) Investments includes $45.9include $24.4 million at June 30, 2020,March 31, 2021, and $40.2$26.9 million at December 31, 20192020 of other T. Rowe Price investment products.

Although we can redeem our net interest in these consolidated T. Rowe Price investment products at any time, we cannot directly access or sell the assets held by these products to obtain cash for general operations. Additionally, the assets of these investment products are not available to our general creditors.

Since third party investors in these investment products have no recourse to our credit, our overall risk related to the net assets of consolidated T. Rowe Price investment products is limited to valuation changes associated with our net interest. We, however, are required to recognize the valuation changes associated with all underlying investments held by these products in our unaudited condensed consolidated statements of income and disclose the portion attributable to third party investors as net income attributable to redeemable non-controlling interests.



Page 13



The operating results of the consolidated T. Rowe Price investment products for the three- and six-three months ended June 30,March 31, 2021 and 2020, and 2019, are reflected in our unaudited condensed consolidated statements of income as follows:
Three months ended
3/31/20213/31/2020
(in millions)Voting interest entitiesVariable interest entitiesTotalVoting interest entitiesVariable interest entitiesTotal
Operating expenses reflected in net operating income$(.2)$(3.3)$(3.5)$(.2)$(3.5)$(3.7)
Net investment income (loss) reflected in non-operating income (loss)6.1 31.1 37.2 (35.2)(295.1)(330.3)
Impact on income before taxes$5.9 $27.8 $33.7 $(35.4)$(298.6)$(334.0)
Net income (loss) attributable to T. Rowe Price Group$4.0 $14.3 $18.3 $(22.6)$(134.9)$(157.5)
Net income (loss) attributable to redeemable non-controlling interests1.9 13.5 15.4 (12.8)(163.7)(176.5)
$5.9 $27.8 $33.7 $(35.4)$(298.6)$(334.0)
 Three months ended
 6/30/2020 6/30/2019
(in millions)Voting interest entities Variable interest entities Total Voting interest entities Variable interest entities Total
Operating expenses reflected in net operating income$(.3) $(3.3) $(3.6) $(.7) $(3.1) $(3.8)
Net investment income (loss) reflected in non-operating income (loss)16.4
 226.0
 242.4
 11.4
 51.4
 62.8
Impact on income before taxes$16.1
 $222.7
 $238.8
 $10.7
 $48.3
 $59.0
            
Net income (loss) attributable to T. Rowe Price Group$12.9
 $100.4
 $113.3
 $5.2
 $25.4
 $30.6
Net income (loss) attributable to redeemable non-controlling interests3.2
 122.3
 125.5
 5.5
 22.9
 28.4
 $16.1
 $222.7
 $238.8
 $10.7
 $48.3
 $59.0


 Six months ended
 6/30/2020 6/30/2019
(in millions)Voting
interest entities
 Variable interest entities Total Voting
interest entities
 Variable interest entities Total
Operating expenses reflected in net operating income$(.5) $(6.8) $(7.3) $(1.0) $(5.9) $(6.9)
Net investment income (loss) reflected in non-operating income(18.8) (69.1) (87.9) 19.4
 145.3
 164.7
Impact on income before taxes$(19.3) $(75.9) $(95.2) $18.4
 $139.4
 $157.8
            
Net income (loss) attributable to T. Rowe Price Group$(9.7) $(34.5) $(44.2) $13.9
 $74.1
 $88.0
Net income (loss) attributable to redeemable non-controlling interests(9.6) (41.4) (51.0) 4.5
 65.3
 69.8
 $(19.3) $(75.9) $(95.2) $18.4
 $139.4
 $157.8


The operating expenses of the consolidated investment products are reflected in other operating expenses. In preparing our unaudited condensed consolidated financial statements, we eliminated operating expenses of $2.1$1.3 million and $2.2$2.5 million for the three months ended June 30,March 31, 2021 and 2020, and 2019, respectively, against the investment advisory and administrative fees earned from these products. Operating expenses eliminated for the six months ended June 30, 2020 and 2019, were $4.6 million and $3.7 million, respectively. The net investment income (loss) reflected in non-operatingnon-

Page 11


operating income (loss) includes dividend and interest income and realized and unrealized gains and losses on the underlying securities held by the consolidated T. Rowe Price investment products.



Page 14



The table below details the impact of these consolidated investment products on the individual lines of our unaudited condensed consolidated statements of cash flows for the sixthree months ended June 30, 2020March 31, 2021 and 2019.2020.
Three months ended
3/31/20213/31/2020
(in millions)
Voting
interest entities
Variable interest entitiesTotalVoting
interest entities
Variable interest entitiesTotal
Net cash provided by (used in) operating activities$(31.7)$(112.0)$(143.7)$11.3 $(87.0)$(75.7)
Net cash used in investing activities(9.1)(18.2)(27.3)(.8)(.8)
Net cash provided by financing activities36.7 112.3 149.0 2.7 116.2 118.9 
Effect of exchange rate changes on cash and cash equivalents of consolidated
T. Rowe Price investment products
.9 .9 (1.2)(1.2)
Net change in cash and cash equivalents during period(4.1)(17.0)(21.1)13.2 28.0 41.2 
Cash and cash equivalents at beginning of year7.1 97.7 104.8 9.9 66.6 76.5 
Cash and cash equivalents at end of period$3.0 $80.7 $83.7 $23.1 $94.6 $117.7 
 Six months ended
 6/30/2020 6/30/2019
(in millions)Voting
interest entities
 Variable interest entities Total Voting
interest entities
 Variable interest entities Total
Net cash provided by (used in) operating activities$.8
 $(49.8) $(49.0) $(32.7) $(258.4) $(291.1)
Net cash used in investing activities(9.2) 
 (9.2) (5.1) 
 (5.1)
Net cash provided by in financing activities9.9
 104.0
 113.9
 34.5
 302.7
 337.2
Effect of exchange rate changes on cash and cash equivalents of consolidated
T. Rowe Price investment products

 (7.4) (7.4) 
 (.4) (.4)
Net change in cash and cash equivalents during period1.5
 46.8
 48.3
 (3.3) 43.9
 40.6
Cash and cash equivalents at beginning of year9.9
 66.6
 76.5
 18.5
 51.6
 70.1
Cash and cash equivalents at end of period$11.4
 $113.4
 $124.8
 $15.2
 $95.5
 $110.7


The net cash provided by financing activities during the sixthree months ended June 30,March 31, 2021 and 2020 and 2019 includes $26.2$34.1 million and $146.9$42.8 million, respectively, of net subscriptions we made into the consolidated T. Rowe Price investment products, net of dividends received. These cash flows were eliminated in consolidation.

FAIR VALUE MEASUREMENTS.

We determine the fair value of investments held by consolidated T. Rowe Price investment products using the following broad levels of inputs as defined by related accounting standards:

Level 1 – quoted prices in active markets for identical securities.
Level 2 – observable inputs other than Level 1 quoted prices including, but not limited to, quoted prices for similar securities, interest rates, prepayment speeds, and credit risk. These inputs are based on market data obtained from independent sources.
Level 3 – unobservable inputs reflecting our own assumptions based on the best information available. The value of investments using Level 3 inputs is insignificant.

These levels are not necessarily an indication of the risk or liquidity associated with these investment holdings. The following table summarizes the investment holdings held by our consolidated T. Rowe Price investment products using fair value measurements determined based on the differing levels of inputs.
6/30/2020 12/31/20193/31/202112/31/2020
(in millions)Level 1 Level 2 Level 1 Level 2(in millions)Level 1Level 2Level 1Level 2
Assets       Assets
Cash equivalents$10.5
 $
 $9.1
 $1.1
Cash equivalents$2.8 $$7.0 $
Equity securities185.1
 668.1
 162.8
 724.5
Equity securities225.7 449.9 308.0 708.0 
Fixed income securities
 1,123.1
 
 1,248.6
Fixed income securities1,107.2 1,411.3 
Other investments2.5
 25.0
 2.7
 33.8
Other investments4.0 35.2 2.6 131.0 
$198.1
 $1,816.2
 $174.6
 $2,008.0
$232.5 $1,592.3 $317.6 $2,250.3 
       
Liabilities$(.6) $(15.4) $(.4) $(11.2)Liabilities$(.4)$(9.9)$(.4)$(18.8)


Page 12


NOTE 6 – STOCKHOLDERS’ EQUITY.

Accounts payable and accrued expenses includes liabilities of $10.6$10.9 million at June 30, 2020,March 31, 2021, and $12.2$2.5 million at December 31, 2019,2020, for common stock repurchases that settled during the first week of July 2020April 2021 and January 2020,2021, respectively.



Page 15


NOTE 7 – STOCK-BASED COMPENSATION.

STOCK OPTIONS.

The following table summarizes the status of, and changes in, our stock options during the sixthree months ended June 30, 2020.March 31, 2021.
 Options 
Weighted-
average
exercise
price
Outstanding at December 31, 20197,388,068
 $71.06
Exercised(1,944,942) $68.29
Forfeited(5,457) $74.09
Outstanding at June 30, 20205,437,669
 $72.05
Exercisable at June 30, 20204,772,891
 $71.52
Options
Weighted-
average
exercise
price
Outstanding at December 31, 20204,329,056 $72.52 
Exercised(748,203)$72.28 
Outstanding at March 31, 20213,580,853 $72.57 
Exercisable at March 31, 20213,580,853 $72.57 


RESTRICTED SHARES AND STOCK UNITS.

The following table summarizes the status of, and changes in, our nonvested restricted shares and restricted stock units during the sixthree months ended June 30, 2020.March 31, 2021.
Restricted
shares
Restricted
stock
units
Weighted-average
fair value
Nonvested at December 31, 20207,412 6,367,059 $116.51 
Time-based grants3,397 $154.03 
Dividend equivalents granted to non-employee directors550 $172.22 
Vested(64,942)$97.37 
Forfeited(19,489)$114.66 
Nonvested at March 31, 20217,412 6,286,575 $116.73 
 
Restricted
shares
 
Restricted
stock
units
 
Weighted-average
fair value
Nonvested at December 31, 20197,404
 6,718,261
 $98.75
Time-based grants7,412
 39,925
 $116.08
Dividend equivalents granted to non-employee directors
 1,243
 $110.74
Vested(7,404) (87,021) $97.44
Forfeited
 (67,294) $96.82
Nonvested at June 30, 20207,412
 6,605,114
 $98.91


Nonvested at June 30, 2020,March 31, 2021, includes403,008 performance-based restricted stock units including 318,768of 361,609. These nonvested performance-based restricted stock units include 198,205 units for which the performance period has expiredlapsed, and the performance threshold has been met.

FUTURE STOCK-BASED COMPENSATION EXPENSE.

The following table presents the compensation expense to be recognized over the remaining vesting periods of the stock-based awards outstanding at June 30, 2020.March 31, 2021. Estimated future compensation expense will change to reflect future grants of restricted stock awards and units, future option grants, changes in the probability of performance thresholds being met, and adjustments for actual forfeitures.
 
(in millions)
Second quarter 2021$56.9 
Third quarter 202156.7 
Fourth quarter 202150.2 
2022117.4 
2023 through 202697.2 
Total$378.4 
(in millions) 
Third quarter 2020$53.6
Fourth quarter 202046.7
2021108.7
2022 through 202690.0
Total$299.0

Page 13


NOTE 8 – EARNINGS PER SHARE CALCULATIONS.

The following table presents the reconciliation of net income attributable to T. Rowe Price Group to net income allocated to our common stockholders and the weighted-average shares that are used in calculating the basic and diluted earnings per share on our common stock. Weighted-average common shares outstanding assuming dilution reflects the potential dilution, determined using the treasury stock method, that could occur if outstanding stock


Page 16



options were exercised and non-participating stock awards vested. NaN outstanding stock options had an anti-dilutive impact on the diluted earnings per common share calculation in the periods presented.
 Three months ended
(in millions)3/31/20213/31/2020
Net income attributable to T. Rowe Price Group749.4 $343.1 
Less: net income allocated to outstanding restricted stock and stock unit holders19.9 9.4 
Net income allocated to common stockholders$729.5 $333.7 
Weighted-average common shares
Outstanding227.7 234.1 
Outstanding assuming dilution230.0 236.8 
 Three months ended Six months ended
(in millions)6/30/2020 6/30/2019 6/30/2020 6/30/2019
Net income attributable to T. Rowe Price Group$603.0
 $527.5
 $946.1
 $1,040.1
Less: net income allocated to outstanding restricted stock and stock unit holders16.8
 13.8
 26.2
 26.8
Net income allocated to common stockholders$586.2
 $513.7
 $919.9
 $1,013.3
        
Weighted-average common shares       
Outstanding227.4
 235.9
 230.7
 236.2
Outstanding assuming dilution229.5
 239.2
 233.1
 239.4


NOTE 9 – OTHER COMPREHENSIVE INCOME AND ACCUMULATED OTHER COMPREHENSIVE LOSS.

The changes in each component of accumulated other comprehensive loss, including reclassification adjustments for the three months ended June 30,March 31, 2021 and 2020 and 2019 are presented in the table below.
  Three months ended 6/30/2020 Three months ended 6/30/2019
(in millions) Equity method investments Consolidated T. Rowe Price investment products - variable interest entities Total currency translation adjustments Equity method investments Consolidated T. Rowe Price investment products - variable interest entities Total currency translation adjustments
Balances at beginning of period $(47.0) $(2.1) $(49.1) $(45.0) $3.4
 $(41.6)
Other comprehensive income (loss) before reclassifications and income taxes (7.3) 5.7
 (1.6) 1.5
 2.7
 4.2
Reclassification adjustments recognized in non-operating income 
 
 
 
 (.1) (.1)
  (7.3) 5.7
 (1.6) 1.5
 2.6
 4.1
Net deferred tax benefits (income taxes) (.1) (1.4) (1.5) (.3) (.7) (1.0)
Other comprehensive income (loss) (7.4) 4.3
 (3.1) 1.2
 1.9
 3.1
Balances at end of period $(54.4) $2.2
 $(52.2) $(43.8) $5.3
 $(38.5)

Three months ended 3/31/2021Three months ended 3/31/2020
(in millions)Equity method investmentsConsolidated T. Rowe Price investment products - variable interest entitiesTotal currency translation adjustmentsEquity method investmentsConsolidated T. Rowe Price investment products - variable interest entitiesTotal currency translation adjustments
Balances at beginning of period$(43.6)$20.6 $(23.0)$(46.9)$3.9 $(43.0)
Other comprehensive income (loss) before reclassifications and income taxes(.8)(7.1)(7.9)(.1)(7.9)(8.0)
Reclassification adjustments recognized in non-operating income(2.6)(2.6)(.1)(.1)
(.8)(9.7)(10.5)(.1)(8.0)(8.1)
Net deferred tax benefits (income taxes).5 2.5 3.0 2.0 2.0 
Other comprehensive income (loss)(.3)(7.2)(7.5)(.1)(6.0)(6.1)
Balances at end of period$(43.9)$13.4 $(30.5)$(47.0)$(2.1)$(49.1)
The other comprehensive income (loss) in the table above excludes $10.3$11.8 million in the 2020 quarter and $1.0$17.2 million in the 2019 quarter of other comprehensive incomeloss related to redeemable non-controlling interests held in our consolidated products.products for the three months ended March 31, 2021 and 2020, respectively.





Page 1714



The changes in each component of accumulated other comprehensive loss, including reclassification adjustments for six months ended June 30, 2020 and 2019, are presented in the table below.
  Six months ended 6/30/2020 Six months ended 6/30/2019
(in millions) Equity method investments Consolidated T. Rowe Price investment products - variable interest entities Total currency translation adjustments Equity method investments Consolidated T. Rowe Price investment products - variable interest entities Total currency translation adjustments
Balances at beginning of period $(46.9) $3.9
 $(43.0) (48.8) 6.8
 (42.0)
Other comprehensive income (loss) before reclassifications and income taxes (7.4) (2.2) (9.6) 6.4
 (1.8) 4.6
Reclassification adjustments recognized in non-operating income 
 (.1) (.1) 
 (.2) (.2)
  (7.4) (2.3) (9.7) 6.4
 (2.0) 4.4
Net deferred tax income taxes (.1) .6
 .5
 (1.4) .5
 (.9)
Other comprehensive income (loss) (7.5) (1.7) (9.2) 5.0
 (1.5) 3.5
Balances at end of period $(54.4) $2.2
 $(52.2) $(43.8) $5.3
 $(38.5)

The other comprehensive income (loss) in the table above excludes $6.9 million for the 2020 period and $.3 million for the 2019 period of other comprehensive losses.

NOTE 10 – COMMITMENTS AND CONTINGENCIES.

On February 14, 2017, T. Rowe Price Group, Inc., T. Rowe Price Associates, Inc., T. Rowe Price Trust Company, current and former members of the management committee, and trustees of the T. Rowe Price U.S. Retirement Program were named as defendants in a lawsuit filed in the United States District Court for the District of Maryland. The lawsuit alleges breaches of ERISA’s fiduciary duty and prohibited transaction provisions on behalf of a class of all participants and beneficiaries of the T. Rowe Price 401(k) Plan from February 14, 2011, to the time of judgment. The matter has been certified as a class action. T. Rowe Price believes the claims are without merit and is vigorously defending the action. This matter isThe parties each filed motions for summary judgment and, with the exception of one claim, the court has denied the parties’ cross motions for summary judgment. A trial has been scheduled to begin in the expert discovery phase of litigation and weSeptember 2021. We cannot predict the eventual outcome, or whether it will have a material negative impact on our financial results, or estimate the possible loss or range of loss that may arise from any negative outcome.

On April 27, 2016, certain shareholders in the T. Rowe Price Blue Chip Growth Fund, T. Rowe Price Capital Appreciation Fund, T. Rowe Price Equity Income Fund, T. Rowe Price Growth Stock Fund, T. Rowe Price International Stock Fund, T. Rowe Price High Yield Fund, T. Rowe Price New Income Fund and T. Rowe Price Small Cap Stock Fund (the “Funds”) filed a Section 36(b) complaint under the caption Zoidis v. T. Rowe Price Assoc., Inc., against T. Rowe Price Associates, Inc. (“T. Rowe Price”) in the United States District Court for the Northern District of California. The complaint alleges that the management fees for the identified funds are excessive because
T. Rowe Price charges lower advisory fees to subadvised clients with funds in the same strategy. The complaint seeks to recover the allegedly excessive advisory fees received by T. Rowe Price in the year preceding the start of the lawsuit, along with investments’ returns and profits. In the alternative, the complaint seeks the rescission of each fund’s investment management agreement and restitution of any allegedly excessive management fees.
T. Rowe Price believes the claims are without merit and is vigorously defending the action. This matter is in the discovery phase of litigation and we cannot predict the eventual outcome, or whether it will have a material negative impact on our financial results, or estimate the possible loss or range of loss that may arise from any negative outcome.

In addition to the mattersmatter discussed above, various claims against us arise in the ordinary course of business, including employment-related claims. In the opinion of management, after consultation with counsel, the likelihood of an adverse determination in one or more of these pending ordinary course of business claims that would have a material adverse effect on our financial position or results of operations is remote.





Page 1815



REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Stockholders and Board of Directors
T. Rowe Price Group, Inc.:

Results of Review of Interim Financial Information
We have reviewed the condensed consolidated balance sheet of T. Rowe Price Group, Inc. and subsidiaries ("the Company"(the “Company") as of June 30, 2020,March 31, 2021, the related condensed consolidated statements of income and comprehensive income, and stockholders’ equity, for the three-month and six-month periods ended June 30, 2020 and 2019, the related condensed consolidated statements of cash flows for the six-monththree-month periods ended June 30,March 31, 2021 and 2020, and 2019, and the related notes (collectively, the consolidated interim financial information). Based on our reviews, we are not aware of any material modifications that should be made to the consolidated interim financial information for it to be in conformity with U.S. generally accepted accounting principles.
We have previously audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheet of the Company as of December 31, 2019,2020, and the related consolidated statements of income, comprehensive income, stockholders’ equity, and cash flows for the year then ended (not presented herein); and in our report dated February 13, 2020,11, 2021, we expressed an unqualified opinion on those consolidated financial statements. In our opinion, the information set forth in the accompanying condensed consolidated balance sheet as of December 31, 2019,2020, is fairly stated, in all material respects, in relation to the consolidated balance sheet from which it has been derived.
Basis for Review Results
This consolidated interim financial information is the responsibility of the Company’s management. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our reviews in accordance with the standards of the PCAOB. A review of consolidated interim financial information consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the PCAOB, the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.

/s/s/ KPMG LLP
Baltimore, Maryland
JulyApril 29, 20202021
 




Page 1916



Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations.

OVERVIEW.

Our revenues and net income are derived primarily from investment advisory services provided to individual and institutional investors in U.S. mutual funds, subadvised funds, separately managed accounts, collective investment trusts, and other T. Rowe Price products. The other T. Rowe Price products include: collective investment trusts,include open-ended investment products offered to investors outside the U.S., and products offered through variable annuity life insurance plans in the U.S. We also provide certain investment advisory clients with related administrative services, including distribution, mutual fund transfer agent, accounting, and shareholder services; participant recordkeeping and transfer agent services for defined contribution retirement plans; brokerage; trust services; and trust services.non-discretionary advisory services through model delivery.

We manage a broad range of U.S., international and global stock, bond, and money market mutual funds and collective investment trusts and other investment products, which meet the varied needs and objectives of individual and institutional investors. Investment advisory revenues depend largely on the total value and composition of assets under our management. Accordingly, fluctuations in financial markets and in the composition of assets under management affect our revenues and results of operations. Additionally, approximately 30% of our operating expenses are impacted by fluctuations in our assets under management.

We incur significant expenditures to develop new products and services and improve and expand our capabilities and distribution channels in order to attract new investment advisory clients and additional investments from our existing clients. These efforts often involve costs that precede any future revenues that we may recognize from an increase to our assets under management.

The general trend to passive investing has been persistent and accelerated in recent years, which has negatively impacted our new client inflows. However, over the long term we expect well-executed active management to play an important role for investors. In this regard, we remain debt-free with ample liquidity and resources that allow us to take advantage of attractive growth opportunities. We are investing in key capabilities, including investment professionals, distribution professionals, technologies, and new product offerings; and, most importantly, weofferings in order to provide our clients with strong investment management expertise and service both now and in the future.service.

MARKET TRENDS.

U.S. equities surgedgenerated strong returns in the first quarter of 2021, a continuation of a remarkably robust stock market given the pandemic and related economic dislocations. Most major U.S. equity indexes hit all-time highs during the second quarter, 2020, bouncing back sharply to recover somealthough the market was led by shares of their steep losses in February and March. Massive stimulus efforts from the Federal Reserve and the federal governmentsmaller companies as well as value stocks and cyclical businesses that are closely tied to the gradual liftinghealth of lockdownsthe economy. Technology and other growth stocks trailed.

In general, equities were lifted by the accelerating rollout of coronavirus vaccines, favorable economic data and corporate earnings reports, and expectations for new federal fiscal stimulus measures. Although Congress passed a $1.9 trillion coronavirus relief bill in March and the reopening of economies drove the market’s vigorous gainsBiden administration prepared to pursue a significant increase in infrastructure spending, some investors were concerned about a sharp increase in longer-term U.S. Treasury yields during the quarter. While most U.S. economic data were dismal, some better-than-expected readingsquarter and possibly higher inflation later in the quarter boosted investor sentiment. However, as the quarter ended, investors were somewhat concerned about increasing coronavirus cases in a number of states, which prompted some governors to stop or reverse some of their reopening efforts.2021.

Stocks in developed non-U.S. equity markets advanced but underperformed U.S. shares.equities; a stronger U.S. dollar versus several key currencies weighed on local returns in U.S. dollar terms. European stock markets were mostly positive despite the reinstatement of lockdown measures in U.S. dollar terms, with German stocks leading the way. Allsome countries. Most developed Asian and Far East markets were positive, with Australia and New Zealand displaying the best returns.posted gains; Japanese stocks returned almost 12% in U.S. dollar terms.shares rose less than 2%.

Emerging markets stocks outperformedalso advanced but underperformed developed non-U.S. markets. Asianmarkets, hurt in part by rising U.S. Treasury yields and a stronger U.S. dollar against many currencies. Latin American markets were positive, with Indonesian shares leading the region. Latin American shares were also very strong, led by Argentina and Brazil.mostly negative in dollar terms. Asian market returns varied widely. In emerging Europe, RussianTurkish shares and the lira tumbled as the Turkish stocks returned about 19%president unexpectedly replaced the head of the central bank shortly after an interest rate increase in U.S. dollar terms.March.





Page 2017



Returns of several major equity market indexes for the three- and six-month periods ended June 30, 2020, were as follows:
  Three months ended Six months ended
Index 6/30/2020 6/30/2020
S&P 500 Index 20.5% (3.1)%
NASDAQ Composite Index(1)
 30.6% 12.1%
Russell 2000 Index 25.4% (13.0)%
MSCI EAFE (Europe, Australasia, and Far East) Index 15.1% (11.1)%
MSCI Emerging Markets Index 18.2% (9.7)%
Three months ended
Index3/31/2021
S&P 500 Index6.2%
NASDAQ Composite Index(1)
2.8%
Russell 2000 Index12.7%
MSCI EAFE (Europe, Australasia, and Far East) Index3.6%
MSCI Emerging Markets Index2.3%
 (1) Returns exclude dividends

Global bonds produced positive returns.bond returns were mostly negative in U.S. dollar terms. In the U.S. investment-grade market,, high yield securities benefited from favorable corporate bonds fared best as credit spreads narrowedearnings and expectations of a stronger economy to post gains. Higher-quality securities with greater interest rate sensitivity were hurt by a sharp increase in part because theintermediate- and long-term U.S. Treasury yields. The Federal Reserve announced that it would begin buying a broad portfolio of U.S. corporate bonds. Asset-backed securities rose to a lesser extent, while mortgage-backed securities and Treasuries lagged with modest returns. The Fed kept short-term interest rates near zero percent;0%, but the 10-year U.S. Treasury note yield decreasedincreased from .70%0.93% to .66%1.74%. Longer-term corporate and U.S. Treasury bonds were among the worst performers. Mortgage- and asset-backed securities fell to a lesser extent. Tax-free municipal bonds produced positive returns but narrowly underperformedheld up relatively well, helped by the broad taxable bond market. High yield bonds easily outperformed the investment-grade market.prospect of more federal aid to shore up state and local finances.

Bonds in developed non-U.S. markets produced gainsdeclined in U.S. dollar terms. Eurozone bond returns toterms, hurt by rising longer-term interest rates in local markets and weaker currencies versus the U.S. investors were helped by dollar weakness againstdollar. The British pound, however, appreciated about 1% versus the Euro.dollar.

Emerging markets bonds displayed strong positive returns. Bondsalso produced negative returns as longer-term interest rates generally increased and a few countries also raised short-term rates. Local currency issues underperformed bonds denominated in U.S. dollars outperformed local currency issues, as weakness in certainmany currencies, such asespecially the Turkish lira and the Brazilian real, andweakened versus the Turkish lira, weighed on local bond performance in U.S. dollar terms.dollar.

Returns for several major bond market indexes for the three- and six-month periods ended June 30, 2020, were as follows:
Three months ended
Index3/31/2021
Bloomberg Barclays U.S. Aggregate Bond Index(3.4)%
JPMorgan Global High Yield Index    1.2%
Bloomberg Barclays Municipal Bond Index(.4)%
Bloomberg Barclays Global Aggregate Ex-U.S. Dollar Bond Index(5.3)%
JPMorgan Emerging Markets Bond Index Plus(7.2)%
  Three months ended Six months ended
Index 6/30/2020 6/30/2020
Bloomberg Barclays U.S. Aggregate Bond Index 2.9% 6.1%
JPMorgan Global High Yield Index     10.8% (5.7)%
Bloomberg Barclays Municipal Bond Index 2.7% 2.1%
Bloomberg Barclays Global Aggregate Ex-U.S. Dollar Bond Index 3.4% .6%
JPMorgan Emerging Markets Bond Index Plus 9.1% (.4)%



Page 2118




ASSETS UNDER MANAGEMENT.

Assets under management ended the secondfirst quarter of 20202021 at $1,220.0$1,518.0 billion, an increase of $211.2$47.5 billion from MarchDecember 31, 20202020. This increase was driven by market appreciation, net of distributions not reinvested, of $46.3 billion and $13.2 billion from the end of 2019. Netnet cash inflows were $14.7 billion, including large subscriptions from institutional clients into U.S. equity and multi-asset, and clientsof $1.2 billion. Clients transferred $4.4$5.6 billion in net assets from the U.S. mutual funds to collective investment trusts and other investment products, of which $1.8$4.9 billion transferred into the retirement date trusts. Market appreciation and income, net of dividends not reinvested, increased our assets under management by $196.5 billion in the second quarter of 2020.

For the six months ended June 30, 2020, net cash inflows were $8.7 billion, and clients transferred $8.8 billion in net assets from the U.S. mutual funds to other investment products, of which $6.1 billion transferred into the retirement date trusts. Market appreciation and income, net of dividends not reinvested, increased our assets under management by $4.5 billion in the six months ended June 30, 2020.

The following tables detail changes in our assets under management, by vehicle and asset class, during the three- and six-month periods ended June 30, 2020:first quarter of 2021:
Three months ended 3/31/2021
(in billions)U.S. mutual fundsSubadvised funds and separate accountsCollective investment trusts and other investment productsTotal
Assets under management at beginning of period$794.6 $400.1 $275.8 $1,470.5 
Net cash flows before client transfers2.0 (8.2)7.4 1.2 
Client transfers(5.6)— 5.6 — 
Net cash flows after client transfers(3.6)(8.2)13.0 1.2 
Net market appreciation and gains25.5 11.9 9.0 46.4 
Net distributions not reinvested(.1)— — (.1)
Change during the period21.8 3.7 22.0 47.5 
Assets under management at March 31, 2021$816.4 $403.8 $297.8 $1,518.0 
 Three months ended 6/30/2020 Six months ended 6/30/2020
(in billions)U.S. mutual funds Subadvised and separate accounts Other investment products Total U.S. mutual funds Subadvised and separate accounts Other investment products Total
Assets under management at beginning of period$562.3
 $261.1
 $185.4
 $1,008.8
 $682.7
 $313.8
 $210.3
 $1,206.8
                
Net cash flows before client transfers3.4
 12.1
 (.8) 14.7
 (4.1) 8.4
 4.4
 8.7
Client transfers(4.4) 
 4.4
 
 (8.8) .2
 8.6
 
Net cash flows after client transfers(1.0) 12.1
 3.6
 14.7
 (12.9) 8.6
 13.0
 8.7
Net market appreciation (depreciation) and income109.7
 54.3
 32.7
 196.7
 1.3
 5.1
 (1.6) 4.8
Net distributions not reinvested(.2) 
 
 (.2) (.3) 
 
 (.3)
Change during the period108.5
 66.4
 36.3
 211.2
 (11.9) 13.7
 11.4
 13.2
                
Assets under management at June 30, 2020$670.8
 $327.5
 $221.7
 $1,220.0
 $670.8
 $327.5
 $221.7
 $1,220.0

Three months ended 6/30/2020 Six months ended 6/30/2020Three months ended 3/31/2021
(in billions)Equity Fixed income, including money market 
Multi-asset(1)
 Total Equity Fixed income, including money market 
Multi-asset(1)
 Total(in billions)EquityFixed income, including money market
Multi-asset(1)
Total
Assets under management at beginning of period$569.3
 $146.3
 $293.2
 $1,008.8
 $698.9
 $147.9
 $360.0
 $1,206.8
Assets under management at beginning of period$895.8 $168.7 $406.0 $1,470.5 
               
Net cash flows9.8
 2.3
 2.6
 14.7
 4.1
 5.3
 (.7) 8.7
Net cash flows(8.9)5.4 4.7 1.2 
Net market appreciation (depreciation) and income(2)
139.8
 4.4
 52.3
 196.5
 15.9
 (.2) (11.2) 4.5
Net market appreciation and gains(2)
Net market appreciation and gains(2)
30.3 (1.3)17.3 46.3 
Change during the period149.6
 6.7
 54.9
 211.2
 20.0
 5.1
 (11.9) 13.2
Change during the period21.4 4.1 22.0 47.5 
Assets under management at June 30, 2020$718.9
 $153.0
 $348.1
 $1,220.0
 $718.9
 $153.0
 $348.1
 $1,220.0
Assets under management at March 31, 2021Assets under management at March 31, 2021$917.2 $172.8 $428.0 $1,518.0 
(1) The underlying assets under management of the multi-asset portfolios have been aggregated and presented in this category and not reported in the equity and fixed income columns.
(2) Includes distributions reinvested and not reinvested.

Investment advisory clients outside the U.S.United States account for about 8.2%8.8% of our assets under management at June 30, 2020March 31, 2021 and 6.9%9.3% at December 31, 2019.2020.


Page 22




Our target date retirement products, which are included in the multi-asset totals shown above, continue to be a significant part of our assets under management. Assets under management in these portfolios, as well as net cash inflows (outflows), by vehicle, were as follows:
Assets under managementNet cash inflows (outflows) for three months ended
(in billions)3/31/202112/31/20203/31/20213/31/2020
U.S. mutual funds$179.9 $176.1 $(3.8)$(5.0)
Collective investment trusts160.3 145.4 8.1 5.6 
Separately managed accounts11.4 10.7 .2 .1 
$351.6 $332.2 $4.5 $.7 
 As of
(in billions)6/30/2020 3/31/2020 12/31/2019
Target date retirement U.S. mutual funds$153.0
 $132.0
 $164.8
Target date separate accounts8.5
 7.1
 8.4
Target date retirement trusts122.7
 103.1
 119.2
 $284.2
 $242.2
 $292.4


Our target dateWe provide participant accounting and plan administration for defined contribution retirement products experienced net cash outflows of $.2 billionplans that invest in the second quarterfirm's U.S. mutual funds, collective investment trusts and funds outside of 2020the firm's complex. As of March 31, 2021, our assets under administration were $248 billion, of which nearly $153 billion are assets we manage. In recent years, we began offering non-discretionary advisory services through model delivery, which are managed accounts where portfolio holdings and net cash inflows of $.5 billiontrades in the first six months of 2020.portfolio are provided to sponsor platforms to implement for their clients.

Page 19


We record the revenue earned on these services in administrative fees. The assets under advisement in these portfolios, predominantly in the United States, is $3 billion at March 31, 2021.

INVESTMENT PERFORMANCE.

Strong
Strong investment performance and brand awareness is a key driver to attracting and retaining assets—and to our long-term success. Our performance disclosures include specific asset classes, assets under management weighted performance, mutual fund performance against passive peers and composite performance against benchmarks. The percentage of our U.S. mutual funds(1) (across primary share classes) that outperformed their comparable Morningstar median on a total return basis and that are in the top Morningstar quartilefollowing table presents investment performance for the one-, three-, five-, and 10-years ended June 30, 2020, were:
  1 year 3 years 5 years 10 years
Outperformed Morningstar median(2)
        
    All funds 59% 63% 73% 77%
    Multi-asset funds 58% 74% 88% 89%
         
Top Morningstar quartile(2)
        
    All funds 29% 34% 46% 52%
    Multi-asset funds 33% 40% 59% 74%
(1) Excludes passive and fund categories not ranked by Morningstar.March 31, 2021. Past performance is no guarantee of future results.
(2)
% of U.S. mutual funds that outperformed Morningstar median(1),(2)
1 year3 years5 years10 years
Equity65%68%67%87%
Fixed Income71%60%55%57%
Multi-Asset94%94%91%90%
All Funds75%73%70%78%
% of U.S. mutual funds that outperformed passive peer median(1),(3)
1 year3 years5 years10 years
Equity57%58%62%72%
Fixed Income91%59%57%60%
Multi-Asset94%91%87%86%
All Funds78%68%68%72%
% of composites that outperformed benchmarks(4)
1 year3 years5 years10 years
Equity55%60%73%78%
Fixed Income87%69%80%72%
All Composites68%63%76%76%

AUM Weighted Performance
% of U.S. mutual funds AUM that outperformed Morningstar median(1),(2)
1 year3 years5 years10 years
Equity63%65%83%94%
Fixed Income79%58%59%60%
Multi-Asset100%96%96%96%
All Funds73%72%84%92%
% of U.S. mutual funds AUM that outperformed passive peer median(1),(3)
1 year3 years5 years10 years
Equity51%53%81%81%
Fixed Income97%52%56%64%
Multi-Asset98%96%96%96%
All Funds66%63%83%84%
% of composites AUM that outperformed benchmarks(4)
1 year3 years5 years10 years
Equity51%65%72%79%
Fixed Income88%54%73%72%
All Composites57%64%73%79%

Page 20


As of March 31, 2021, 80 of 123 (65.0%) of the firm's rated U.S. mutual funds (across primary share classes) received an overall rating of 4 or 5 stars. By comparison, 32.5% of Morningstar's fund population is given a rate of 4 or 5 stars(5). In addition, 88%(5) of AUM in the firm's rated U.S. mutual funds (across primary share classes) ended March 31, 2021 with an overall rating of 4 or 5 stars.

(1) Source: © 20202021 Morningstar, Inc. All rights reserved. The information contained herein: (1)1) is proprietary to Morningstar and/or its content providers; (2)2) may not be copied or distributed; and (3)3) is not warranted to be accurate, complete, or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.

In addition, 79% of assets under management in our rated U.S.(2)Source: Morningstar. Primary share class only. Excludes money market mutual funds, (across primary share classes) ended the quarterfunds with an overall ratingoperating history of four or five starsless than one year, T. Rowe Price passive funds, and T. Rowe Price funds that are clones of other funds. The top chart reflects the percentage of T. Rowe Price funds with 1 year, 3 year, 5 year, and 10 year track record that are outperforming the Morningstar category median. The bottom chart reflects the percentage of T. Rowe Price funds AUM that has outperformed for the time periods indicated. Total AUM included for this analysis includes $503B for 1 year, $503B for 3 years, $503B for 5 years, and $493B for 10 years.
(3) Passive Peer Median was created by T. Rowe Price using data from Morningstar. Primary share class only. Excludes money market mutual funds, funds with an operating history of less than one year, funds with fewer than three peers, T. Rowe Price passive funds, and T. Rowe Price funds that are clones of other funds. This analysis compares T. Rowe Price active funds to the applicable universe of passive/index open-end funds and ETFs of peer firms. The top chart reflects the percentage of T. Rowe Price funds with 1 year, 3 year, 5 year, and 10 year track record that are outperforming the passive peer universe. The bottom chart reflects the percentage of T. Rowe Price funds AUM that has outperformed for the time periods indicated. Total AUM included for this analysis includes $491B for 1 year, $482B for 3 years, $439B for 5 years, and $416B for 10 years.
(4)Composite net returns are calculated using the highest applicable separate account fee schedule. Excludes money market composites. All composites compared to official GIPS composite primary benchmark. The top chart reflects the percentage of T. Rowe Price composites with 1 year, 3 year, 5 year, and 10 year track record that are outperforming their benchmarks. The bottom chart reflects the percentage of T. Rowe Price composite AUM that has outperformed for the time periods indicated. Total AUM included for this analysis includes $1,392B for 1 year, $1,388B for 3 years, $1,364B for 5 years, and $1,316B for 10 years.
(5) The Morningstar Rating™ for funds is calculated for funds with at least a three-year history. Exchange-traded funds and open-ended mutual funds are considered a single population for comparative purposes. It is calculated based on a Morningstar Risk-Adjusted Return measure that accounts for variation in a managed product's monthly excess performance, placing more emphasis on downward variations and rewarding consistent performance. Morningstar gives its best ratings of our institutional strategies against their benchmarks remains competitive, especially over longer time periods.5 or 4 stars to the top 32.5% of all funds (of the 32.5%,10% get 5 stars and 22.5% get 4 stars). The Overall Morningstar Rating™ is derived from a weighted average of the performance figures associated with a fund’s 3, 5, and 10 year (if applicable) Morningstar Rating™ metrics.


RESULTS OF OPERATIONS.

The following table and discussion sets forth information regarding our consolidated financial results for the three and six months ended June 30,March 31, 2021 and 2020 and 2019 on a U.S. GAAP basis as well as a non-GAAP basis. The non-GAAP basis adjusts for the impact of our consolidated T. Rowe Price investment products, the impact of market movements on the supplemental savings plan liability and related economic hedges, investment income related to certain other investments, and certain nonrecurring charges and gains.gains, if any.


Page 23


Three months ended Q2 2020 vs. Q2 2019  Six months ended YTD 2020 vs. YTD 2019Three months endedQ1 2021 vs. Q1 2020
(in millions, except per-share data)6/30/2020 6/30/2019 $ change % change  6/30/2020 6/30/2019 $ change % change(in millions, except per-share data)3/31/20213/31/2020$ change% change
U.S. GAAP basis                U.S. GAAP basis
Investment advisory fees$1,293.8
 $1,270.2
 $23.6
 1.9 %  $2,621.6
 $2,464.4
 $157.2
 6.4 %Investment advisory fees$1,687.8 $1,327.8 $360.0 27.1 %
Net revenues$1,415.4
 $1,395.2
 $20.2
 1.4 %  $2,878.0
 $2,722.5
 $155.5
 5.7 %Net revenues$1,826.8 $1,462.6 $364.2 24.9 %
Operating expenses$861.7
 $780.1
 $81.6
 10.5 %  $1,617.1
 $1,574.9
 $42.2
 2.7 %Operating expenses$933.6 $755.4 $178.2 23.6 %
Net operating income$553.7
 $615.1
 $(61.4) (10.0)%  $1,260.9
 $1,147.6
 $113.3
 9.9 %Net operating income$893.2 $707.2 $186.0 26.3 %
Non-operating income (loss)(1)
$415.1
 $124.5
 $290.6
 n/m
  $(85.2) $327.3
 $(412.5) n/m
Non-operating income (loss)(1)
$102.1 $(500.3)$602.4 n/m
Net income attributable to T. Rowe Price Group$603.0
 $527.5
 $75.5
 14.3 %  $946.1
 $1,040.1
 $(94.0) (9.0)%Net income attributable to T. Rowe Price Group$749.4 $343.1 $406.3 118.4 %
Diluted earnings per common share$2.55
 $2.15
 $.40
 18.6 %  $3.95
 $4.23
 $(.28) (6.6)%Diluted earnings per common share$3.17 $1.41 $1.76 124.8 %
Weighted average common shares outstanding assuming dilution229.5
 239.2
 (9.7) (4.1)%  233.1
 239.4
 (6.3) (2.6)%Weighted average common shares outstanding assuming dilution230.0 236.8 (6.8)(2.9)%
                
Adjusted non-GAAP basis(2)
Adjusted non-GAAP basis(2)
               
Adjusted non-GAAP basis(2)
Operating expenses$785.8
 $764.6
 $21.2
 2.8 %  $1,603.7
 $1,521.2
 $82.5
 5.4 %Operating expenses$909.2 $817.9 $91.3 11.2 %
Net operating income$631.7
 $632.8
 $(1.1) (.2)%  $1,278.9
 $1,205.0
 $73.9
 6.1 %Net operating income$918.9 $647.2 $271.7 42.0 %
Non-operating income(1)
$85.8
 $35.8
 $50.0
 n/m
  $24.6
 $80.0
 $(55.4) n/m
Non-operating income (loss)(1)
Non-operating income (loss)(1)
$13.7 $(61.2)$74.9 n/m
Net income attributable to T. Rowe Price Group$539.6
 $498.1
 $41.5
 8.3 %  $993.9
 $958.7
 $35.2
 3.7 %Net income attributable to T. Rowe Price Group$712.0 $454.3 $257.7 56.7 %
Diluted earnings per common share$2.29
 $2.03
 $.26
 12.8 %  $4.15
 $3.90
 $.25
 6.4 %Diluted earnings per common share$3.01 $1.87 $1.14 61.0 %
                
Assets under management (in billions)
Assets under management (in billions)
             
Assets under management (in billions)
Average assets under management$1,140.2
 $1,099.8
 $40.4
 3.7 %  $1,151.4
 $1,071.8
 $79.6
 7.4 %Average assets under management$1,508.8 $1,162.7 $346.1 29.8 %
Ending assets under management$1,220.0
 $1,125.0
 $95.0
 8.4 %  $1,220.0
 $1,125.0
 $95.0
 8.4 %Ending assets under management$1,518.0 $1,008.8 $509.2 50.5 %
(1) The percentage change in non-operating income (loss) is not meaningful (n/m).
(2) See the reconciliation to the comparable U.S. GAAP measures at the end of the Results of Operations section of this Management’s Discussion and Analysis.

Results Overview - Quarter ended June 30, 2020March 31, 2021

Investment advisory revenues. Investment advisory fees are earned based on the value and composition of our assets under management, which change based on fluctuations in financial markets and net cash flows. As our average assets under management increase or decrease in a given period, the level of our investment advisory fee

Page 21


revenue for that same period generally fluctuates in a similar manner. Our annualized effective fee rates can be impacted by market or cash flow related shifts among asset and share classes, price changes in existing products, and asset level changes in products with tiered-fee structures.

Investment advisory revenues earned in the secondfirst quarter of 20202021 increased over the comparable 20192020 quarter as average assets under our management increased $40.4$346.1 billion, or 3.7%29.8%, to $1,140.2$1,508.8 billion. In the first quarter of 2021, we voluntarily waived $15.0 million, or less than 1%, of our investment advisory fees in order to continue to maintain a positive yield for investors. At March 31, 2021, combined net assets of the investment portfolios in which we waived fees in the first quarter of 2021 were $29.5 billion. We expect to continue to waive fees for all of 2021 and anticipate that the waivers in each of the next three quarters of 2021 will be at similar levels.

The average annualized effective fee rate earned during the secondfirst quarter of 20202021 was 45.645.4 basis points, compared with 46.345.9 basis points earned during the second quarter of 2019.

Further, beginning in the secondfirst quarter of 2020 we voluntarily waived a portion of our money market advisory fees and fund expenses in order to maintain a positive yield for investors. We waived $2.7 million, or less than 1% of total investment advisory fees from certain of our money market mutual funds, trusts and other investment portfolios45.7 basis points during the secondfourth quarter of 2020. At June 30, 2020, combined net assets ofIn comparison to the funds and trusts in which we waived fees in the secondfirst quarter of 2020, were $22.4 billion. We expect to continue to waive fees for at least the remainder of 2020.

Ourour annualized effective fee rate declined primarily due to client transfers within the complex to lower fee vehicles or share classes over the last twelve months.months and the money market fee waivers. In comparison to the fourth quarter of 2020, our average annualized effective fee rate declined primarily due to lower performance fees earned in 2021.



Page 24


Operating expenses. Operating expenses were $861.7$933.6 million in the secondfirst quarter of 20202021 compared with $780.1$755.4 million in the secondfirst quarter of 2019. The2020. Nearly half of the increase in operating expenses for the secondfirst quarter of 2021 compared to the first quarter of 2020 was primarily due to an $85.9 million increase in market-related compensation expense of $60.5 million related to the increase in the supplemental savings plan liabilityfrom higher market returns. The remaining increase was due primarily to higher compensation expenses as well as distribution and to a lesser extent, higher salaries and the firm’s continued strategic investments.servicing costs. For the secondfirst quarter of 2020,2021, the higher compensation expense related to the supplemental savings plan was largelyalmost entirely offset by the non-operating gains earned on the investments used to economically hedge the related liability.

On a non-GAAP basis, our operating expenses in the secondfirst quarter of 20202021 increased 2.8%11.2% to $785.8$909.2 million compared to the secondfirst quarter of 2019.2020. Our non-GAAP operating expenses do not include the impact of our supplemental savings plan and consolidated sponsored investment products. See our non-GAAP reconciliations later in this Management’s Discussion and Analysis section.

In 2021 and beyond, we expect to advance our strategic priorities to maintain our position as a global and diversified asset manager, a global partner for retirement investors and a provider of integrated investment solutions; to embed environmental, social and governance principles across the firm; to maintain effective processes and controls while becoming a more adaptive and agile firm; and to become a destination of choice for top talent with a diverse workforce and inclusive culture. We updated our 2021 non-GAAP operating expense growth guidance from a range of 8% - 12% to a range of 10% - 14% to reflect an increase in our expectations for AUM-related expenses. We can elect to adjust our expense growth in the future should unforeseen circumstances arise, including significant market movements.

Operating margin. Our operating margin in the secondfirst quarter of 20202021 was 39.1%48.9%, compared to 44.1%48.4% earned in the 20192020 quarter. The decreaseincrease in our operating margin for the secondfirst quarter of 20202021 compared to the 20192020 period was primarily driven by higher investment advisory fee revenue, partially offset by the higher compensation expense related to our supplemental savings plan, as marketsmarket returns in the secondfirst quarter of 20202021 outperformed the same period in 2019.2020.

Diluted earnings per share. Diluted earnings per share was $2.55$3.17 for the secondfirst quarter of 20202021 as compared to $2.15$1.41 for the secondfirst quarter of 2019.2020. The 18.6%124.8% increase was primarily driven by the significantly highernet investment gains recognized in the secondfirst quarter of 2021 as compared to significant investment losses recognized in the first quarter of 2020 as compared tofollowing sharp market declines at the second quarterend of 2019 as well as a 4.1% decline in weighted average shares outstanding. These drivers of the increase in diluted earnings per share were partially offset by lower operating income in the second quarter ofMarch 2020.

On a non-GAAP basis, diluted earnings per share was $2.29$3.01 for the secondfirst quarter of 20202021 as compared to $2.03$1.87 for the secondfirst quarter of 2019.2020. The increase in diluted earnings per share was primarily due to higher investmentoperating income as well as net gains and lower shares outstanding.

Results Overview - Year-to-Date ended June 30, 2020
Investment advisory revenues.Investment advisory revenues earned in the six months ended June 30, 2020 increased over the comparable 2019 period as average assets under our management increased $79.6 billion, or 7.4%, to $1,151.4 billion. The average annualized effective fee rate earned on our assets under management duringcash and discretionary investments in the six months ended June 30, 2020 was 45.8 basis points2021 quarter compared with 46.4 basis points earned during the same period of 2019.

Our annualized effective fee rate declined primarily due to client transfers within the complex to lower fee vehicles or share classes over the last twelve months.

Operating expenses.Operating expenses were $1,617.1 million in the six months ended June 30, 2020 compared with $1,574.9 million in the 2019 period. The increase in operating expenses was primarily due to higher salary and benefits expense, interim bonus accrual, stock-based compensation expense and our continued strategic investments. These increases were partially offset by lower market-related compensation expense of $39.8 million related to the supplemental savings plan.

On a non-GAAP basis, our operating expenses for the six months ended June 30, 2020 increased 5.4% to $1,603.7 million compared to the 2019 period. Our non-GAAP operating expenses do not include the impact of our supplemental savings plan and consolidated sponsored investment products. See our non-GAAP reconciliations later in this Management’s Discussion and Analysis section.

While we anticipate that the coronavirus pandemic will continue to reduce certain expense categories, such as travel, we have changed our expected full-year 2020 non-GAAP operating expense growth to 3%-6%, from the 1%-4% provided in April 2020 as the sharp market recovery in the second quarter of 2020 has increased our AUM-related expenses. This range includes investments in our critical strategic initiatives to promote long-term growth of the business. We could elect to further adjust our expense growth should unforeseen circumstances arise, including significant market movements and ongoing disruption resulting from the coronavirus pandemic.

Operating margin. Our operating margin in the six months ended June 30, 2020 was 43.8%, compared to 42.2% earned in the 2019 period. The increase in our operating margin for the six months ended June 30, 2020 compared


Page 25


to the 2019 period was primarily driven by the lower compensation expense related to our supplemental savings plan as markets in the first half of 2020 underperformed the same period in 2019 as global markets were disrupted by the coronavirus pandemic during 2020.

Diluted earnings per share. Diluted earnings per share was $3.95 for the six months ended June 30, 2020 as compared to $4.23 for the six months ended June 30, 2019. The 6.6% decrease was primarily driven by investment losses recognized in the six months ended June 30, 2020 as compared to gains generated in the six months ended June 30, 2019. Higher operating income, lower outstanding shares, and a lower effective tax rate in the first half of 2020 reduced the impact of the investment losses.

Diluted earnings per share on a non-GAAP basis was $4.15 for the six months ended June 30, 2020 as compared to $3.90 for the six months ended June 30, 2019. The increase in adjusted diluted earnings per share was primarily due to higher operating income, lower shares outstanding, and a lower effective tax rate. The impact of these drivers were partially offset by investment losses recognized in the 2020 period. See our non-GAAP reconciliations later in this Management’s Discussion and Analysis section.



Page 22


Net revenues
Three months endedQ1 2021 vs. Q1 2020
(in millions)3/31/20213/31/2020$ change% change
Investment advisory fees
U.S. mutual funds$1,050.2 $876.2 $174.0 19.9 %
Subadvised funds, separate accounts, collective investment trusts, and other investment products637.6 451.6 186.0 41.2 %
1,687.8 1,327.8 360.0 27.1 %
Administrative, distribution, and servicing fees
Administrative fees109.9 106.9 3.0 2.8 %
Distribution and servicing fees29.1 27.9 1.2 4.3 %
139.0 134.8 4.2 3.1 %
Net revenues$1,826.8 $1,462.6 $364.2 24.9 %
 Three months ended Q2 2020 vs. Q2 2019  Six months ended YTD 2020 vs. YTD 2019
(in millions)6/30/2020 6/30/2019 $ change % change  6/30/2020 6/30/2019 $ change % change
Investment advisory fees                
U.S. mutual funds$823.1
 $860.7
 $(37.6) (4.4)%  $1,699.3
 $1,676.6
 $22.7
 1.4 %
Subadvised and separate accounts and other investment products470.7
 409.5
 61.2
 14.9 %  922.3
 787.8
 134.5
 17.1 %
 1,293.8
 1,270.2
 23.6
 1.9 %  2,621.6
 2,464.4
 157.2
 6.4 %
Administrative, distribution, and servicing fees                
Administrative fees95.9
 94.9
 1.0
 1.1 %  202.8
 197.8
 5.0
 2.5 %
Distribution and servicing fees25.7
 30.1
 (4.4) (14.6)%  53.6
 60.3
 (6.7) (11.1)%
 121.6
 125.0
 (3.4) (2.7)%  256.4
 258.1
 (1.7) (.7)%
Net revenues$1,415.4
 $1,395.2
 $20.2
 1.4 %  $2,878.0
 $2,722.5
 $155.5
 5.7 %

Investment advisory fees.

U.S. mutual funds
Investment advisory revenues earned in the secondfirst quarter of 20202021 from our U.S. mutual funds were $823.1$1,050.2 million, a decreasean increase of 4.4%19.9% from the comparable 20192020 quarter. Average assets under management in these funds for the secondfirst quarter of 2020 decreased 1.6%2021 increased 24.5% from the 20192020 quarter to $628.6$814.5 billion.

For the first quarter of 2021, the relationship between U.S. mutual funds’ average assets under management and investment advisory fee growth was impacted primarily by the money market fee waivers. In addition, strong market returns led to a decrease in the fee earned as the asset levels of certain tiered-fee funds crossed a new tier.

Subadvised funds, separate accounts, collective investment trusts and other investment products (other portfolios)
Investment advisory revenues earned in the six months ended June 30, 2020first quarter of 2021 from the firm's U.S. mutual fundsthese other portfolios were $1,699.3$637.6 million, an increase of 1.4%41.2% from the comparable 2019 period. Average assets under management in these funds for the six months ended June 30, 2020 increased 2.7% from the 2019 period to $641.5 billion.

The difference in the percentage of change in revenue compared with assets under management for both the 2020 quarter and year-to-date periods from the 2019 period is primarily due to client transfers within the complex to lower fee vehicles or shares classes during the last twelve months.

Subadvised and separate accounts and other investment products
Investment advisory revenues earned in the second quarter of 2020 from subadvised and separate accounts and other investment products were $470.7 million, an increase of 14.9% from the comparable 2019 quarter. Average assets under management for these products increased 10.9%36.6% from the 20192020 quarter to $511.6$694.3 billion.



Page 26


Investment advisory revenues earned inFor the six months ended June 30, 2020 from subadvised and separate accounts as well as other investmentportfolios, inflows into our international products, were $922.3 million, an increase of 17.1% from the 2019 period. Average assets under management for these products increased 14.0% from the 2019 period to $509.9 billion.

Inflows into the Japanese ITMs, which have a higher than average fee rate have causedrelative to other products, and performance-based fees earned on certain separate accounts drove investment advisory fees in these portfoliosrevenues to increase at a rate greater thanoutpace the increase in their average assets under management. The fee rate earned on

These investment advisory revenues include distribution-related services we provide to the Japanese ITMs is substantially offset by the costs incurredinternational products and then contract with third-party intermediaries to distribute these products. ThoseThe costs we incur to pay the third-party intermediaries are recorded as part of distribution and servicing expenses.

Administrative, distribution, and servicing fees. Administrative, distribution, and servicing fees in the secondfirst quarter of 20202021 were $121.6$139.0 million, a decreasean increase of $3.4$4.2 million, or 2.7%3.1%, from the comparable 20192020 quarter. For the six months ended June 30, 2020, these fees were $256.4 million, a decrease of $1.7 million, or .7%, from the 2019 period. In this line, we recognize fees earned from providing administrative and distribution services to our investment advisory clients, primarily our U.S. mutual funds and their investors. The decrease for both periodsincrease was primarily due to lowerhigher transfer agent servicing activities provided to the U.S. mutual funds, higher model delivery revenue, as well as higher 12b-1 revenue earned on certainthe R share classes, including the Advisor and R classes,class of the U.S. mutual funds as lower markets in 2020 as well as client transfers to lower fee vehicles and share classes over the last twelve months have reduceda result of increased assets under management in thesethis share classes.class. The declineincrease in 12b-1 revenue is offset entirely by a reductionan increase in the costs paid to third-party intermediaries that source these assets and reported in distribution and servicing expense. For the six months ended June 30, 2020 compared to the same period of 2019, the lower 12b-1 revenue was partially offset by increased retail transfer agent servicing activities and higher administrative services provided to fund shareholders.

Our second quarter net revenues reflect the elimination of $2.1 million in 2020advisory and $2.2 million in 2019, ofadministrative fee revenue earned from our consolidated
T. Rowe Price investment products. For the six months ended June 30, 2020 and 2019, we eliminated $4.6 million in 2020 and $3.7 million in 2019 of net revenue. The corresponding expenses recognized by these products, and consolidated in our financial statements, were also eliminated from operating expenses. For the first quarter, we eliminated net revenue of $1.3 million in 2021 and $2.5 million in 2020.



Page 23


Operating expenses
Three months endedQ1 2021 vs. Q1 2020
(in millions)3/31/20213/31/2020$ change% change
Compensation and related costs, excluding supplemental savings plan$561.3 $504.4 $56.9 11.3 %
Supplemental savings plan(1)
22.2 (63.7)85.9 n/m
  Total compensation and related costs583.5 440.7 142.8 32.4 %
Distribution and servicing85.6 65.7 19.9 30.3 %
Advertising and promotion18.9 24.9 (6.0)(24.1)%
Product-related costs41.0 41.6 (.6)(1.4)%
Technology, occupancy, and facility costs117.3 105.4 11.9 11.3 %
General, administrative, and other87.3 77.1 10.2 13.2 %
Total operating expenses$933.6 $755.4 $178.2 23.6 %
 Three months ended Q2 2020 vs. Q2 2019  Six months ended YTD 2020 vs. YTD 2019
(in millions)6/30/2020 6/30/2019 $ change % change  6/30/2020 6/30/2019 $ change % change
Compensation and related costs$549.0
 $483.2
 $65.8
 13.6 %  $989.7
 $974.7
 $15.0
 1.5 %
Distribution and servicing62.0
 64.4
 (2.4) (3.7)%  127.7
 130.8
 (3.1) (2.4)%
Advertising and promotion13.4
 19.8
 (6.4) (32.3)%  38.3
 41.4
 (3.1) (7.5)%
Product-related costs39.6
 33.4
 6.2
 18.6 %  81.2
 77.6
 3.6
 4.6 %
Technology, occupancy, and facility costs111.3
 104.9
 6.4
 6.1 %  216.7
 203.0
 13.7
 6.7 %
General, administrative, and other86.4
 74.4
 12.0
 16.1 %  163.5
 147.4
 16.1
 10.9 %
Total operating expenses$861.7
 $780.1
 $81.6
 10.5 %  $1,617.1
 $1,574.9
 $42.2
 2.7 %
(1) The impact of the market on the supplemental savings plan liability drives the expense recognized each period.

Compensation and related costs.costs, excluding supplemental savings plan. Compensation and related costs, excluding supplemental savings plan, were $549.0$561.3 million in the secondfirst quarter of 2020,2021, an increase of $65.8$56.9 million, or 13.6%11.3%, compared to the 20192020 quarter. The increase from the 2020 quarter was primarily due to anstrong operating results in the first quarter of 2021 that led to a $36.3 million increase in market-related expense of $60.5 million relatedour interim accrual for annual variable compensation, primarily bonus compensation. Also contributing to our supplemental savings plan as the sharp market recoveryincrease in 2021 costs compared to the secondfirst quarter of 2020 increased the liability. Additionally, increaseswas a $22.6 million increase in base salaries and related employee costs,benefits due to a 5.1%3.4% increase in our average staff size and to a lesser extent, the modest increases in base salaries at the beginning of 2020, and higher non-cash stock-based compensation expense contributed to the increase in compensation and related costs in the 2020 period.year. These increases in compensation and related costs were offset in part by higher labor capitalization related to internally developed software and a lower interim accrual for annual variable compensation, primarily bonus compensation, from the 2019 quarter. We recognize the interim bonus accrual ratably over the year using the ratio of recognized quarterly net revenues to currently forecasted annual net revenues.software.

Compensation and related costs were $989.7 million in the six months ended June 30, 2020, an increase of $15.0 million, or 1.5%, compared to the 2019 period. The increase in compensation and related costs was primarily due to an increase in salaries, benefits and related employee costs, which have increased $32.2 million from the 2019


Page 27


period. An increase of 5.4% in our average staff size and modest increases in base salaries at the beginning of 2020 have contributed to higher associate-related costs. Our interim accrual for annual variable compensation, primarily bonus compensation, also increased $10.8 million in 2020 from the 2019 period. These increases in compensation and related costs were offset in part by $39.8 million in lower market-related expense related to our supplemental savings plan and $13.0 million in higher labor capitalization related to internally developed software in 2020 period.
Distribution and servicing. Distribution and servicing includes those costs incurred to distribute T. Rowe Price products as well as client and shareholder servicing, recordkeeping, and administrative services. These costs were $62.0$85.6 million for the secondfirst quarter of 2020, a decrease2021, an increase of 3.7%30.3% from the $64.4$65.7 million recognized in the 20192020 quarter. For the six months ended June 30, 2020, these costs were $127.7 million, a decrease of 2.4% over the $130.8 million recognized in the comparable 2019 period. The decrease for both periodsincrease is primarily driven by lower assets under management in those mutual funds for which we pay distribution and servicing costs as lower markets and client transfers to lower fee vehicles or share classes over the last twelve months reduced assets under management for these share classes. The decreases in costs related to these products were partially offset by higher distribution costs as a result of continued inflows intoand market appreciation in our international products, including our Japanese ITMs.Investment Trusts (ITMs) and SICAVs.

Distribution and servicing costs paid to third-party intermediaries that source the assets of certain share classes of our U.S. mutual funds and our international products, such as our Japanese ITMs and SICAVs, are recognized in this expense line andexpense. Both of these costs are offset entirely by the 12b-1 revenue we earn and report in net revenues: 12b-1 revenue recognized in administrative, distribution, and servicing fees.fees for the U.S. mutual funds and investment advisory fee revenue for our international products.

Advertising and promotion. Advertising and promotion costs were $13.4$18.9 million in the secondfirst quarter of 2020, 2021, a decrease of $6.4$6.0 million,, or 32.3%24.1%, compared to the $19.8$24.9 million recognized in the 20192020 quarter. ForThe decrease is driven primarily by the six months ended June 30,timing of media-related spend as well as fewer conference and promotional events since the later part of the first quarter of 2020 these costs were $38.3 million, a decrease of $3.1 million, or 7.5%, compareddue to the 2019 period. The decrease for both periods is due primarily to lower media activity and fewer conference events in 2020 as compared to 2019.coronavirus pandemic.
Technology, occupancy, and facility costs. Technology, occupancy, and facility costs consists of depreciation expense, technology equipment and maintenance, software, and costs related to our facilities. These costs were $111.3$117.3 million in the secondfirst quarter of 2020,2021, an increase of $6.4$11.9 million, or 6.1%11.3%, compared to the $104.9$105.4 million recognized in the 20192020 quarter. For the six months ended June 30, 2020, these costs were $216.7 million, an increase of $13.7 million, or 6.7%, compared to the 2019 period. The increase for both periods is due primarily to the ongoing investment in our technology capabilities, including relatedhosted solution licenses and depreciation, and hosted solution licenses.higher office lease costs.

General, administrative, and other. General, administrative, and other expenses were $86.4$87.3 million in the secondfirst quarter of 2020, an increase2021, a decrease of $12.0$10.2 million, or 16.1%13.2%, compared to the $74.4$77.1 million recognized in the 20192020 quarter. For the six months ended June 30, 2020, theseThe timing of when certain general and administrative costs were $163.5 million, an increaseincurred in the first quarter of $16.1 million, or 10.9%,2021 compared to the 2019 period. The increase for both periods is primarily due2020 period contributed to certain nonrecurringthe higher costs. Lower travel-related expenses nearly offset increases in other general and administrative expenses, along with higher third-party investment research costs and higher professional fees. These increases were partially offset by lower travel expenses in the second quarter of 2020.costs.

Non-operating income (loss)

Non-operating income for the secondfirst quarter of 20202021 was $415.1$102.1 million, an increase of $290.6$602.4 million from non-operating incomeloss of $500.3 million in the second quarter of 2019 of $124.5 million. Non-operating loss for the six months ended June 30, 2020 was $85.2 million, a decrease of $412.5 million from non-operating income in the comparable 2019 period of $327.3 million.quarter. The following table details the components of non-operating income (loss) for both the first quarter of March 31, 2021 and year-to-date periods.


2020.

Page 2824


Three months ended Six months endedThree months ended
(in millions)6/30/2020 6/30/2019 6/30/2020 6/30/2019(in millions)3/31/20213/31/2020
Net gains (losses) from non-consolidated T. Rowe Price investment products       Net gains (losses) from non-consolidated T. Rowe Price investment products
Cash and discretionary investments       Cash and discretionary investments
Dividend income$5.0
 $17.9
 $15.4
 $34.1
Dividend income$5.1 $10.4 
Market related gains and equity in earnings80.8
 17.9
 9.2
 45.9
Market related gains (losses) and equity in earnings (losses)Market related gains (losses) and equity in earnings (losses)8.6 (71.6)
Total cash and discretionary investmentsTotal cash and discretionary investments13.7 (61.2)
Seed capital investments       Seed capital investments
Dividend income.5
 .3
 1.2
 .8
Dividend income.1 .7 
Market related gains (losses) and equity in earnings (losses)28.1
 8.7
 (6.0) 28.3
Market related gains (losses) and equity in earnings (losses)11.9 (34.1)
Net gain recognized upon deconsolidation
 .1
 .1
 .2
Net gain recognized upon deconsolidation2.6 .1 
Investments used to hedge the supplemental savings plan liability64.4
 12.1
 (4.1) 43.1
Investments used to hedge the supplemental savings plan liability22.1 (68.5)
Total net gains from non-consolidated T. Rowe Price investment products178.8
 57.0
 15.8
 152.4
Other investment income (loss)(8.2) 4.8
 .2
 9.5
Total net gains (losses) from non-consolidated T. Rowe Price investment productsTotal net gains (losses) from non-consolidated T. Rowe Price investment products50.4 (163.0)
Other investment incomeOther investment income18.2 8.4 
Net gains (losses) on investments170.6
 61.8
 16.0
 161.9
Net gains (losses) on investments68.6 (154.6)
Net gains (losses) on consolidated sponsored investment portfolios242.4
 62.8
 (87.9) 164.7
Net gains (losses) on consolidated sponsored investment portfolios37.2 (330.3)
Other income (loss), including foreign currency gains and losses2.1
 (.1) (13.3) .7
Other income (loss), including foreign currency gains and losses(3.7)(15.4)
Non-operating income (loss)$415.1
 $124.5
 $(85.2) $327.3
Non-operating income (loss)$102.1 $(500.3)

OurThe impact of strong market returns on our investment portfolio recognized significant gains in the second quarter of 2020 as the markets rebounded sharply from the market losses experienced in the first quarter of 2020.2021 compared with significant market losses in the first quarter of 2020 drove the increase in non-operating income. Our consolidated investment products and supplemental savings plan hedge portfolio comprised about 75%more than half of the net gains recognized during the secondfirst quarter of 2020. The2021. Our cash and discretionary investment portfolio also experienced net investment gains of $85.8$13.7 million in the second quarter of 2020.

Despite the sharp market recovery in the second quarter of 2020, our investment portfolio for the six months ended June 30, 2020 has experienced net losses due to the global economies and markets disruption caused by the coronavirus pandemic in the first quarter of 2020. Our consolidated investment products and supplemental savings plan hedge portfolio comprised most of the net losses recognized during the six months ended June 30, 2020. The cash and discretionary investment portfolio partially offset these losses with net investment gains of $24.6 million in the six months ended June 30, 2020.2021.

The table above includes the net investment income of the underlying portfolios included in the consolidated T. Rowe Price investment products and not just the net investment income related to our interest. The table below shows the impact that the consolidated T. Rowe Price investment products had on the individual lines of our unaudited condensed consolidated statements of income and the portion attributable to our interest:
 Three months ended Six months ended
(in millions)6/30/2020 6/30/2019 6/30/2020 6/30/2019
Operating expenses reflected in net operating income$(3.6) $(3.8) $(7.3) $(6.9)
Net investment income (loss) reflected in non-operating income (loss)242.4
 62.8
 (87.9) 164.7
Impact on income before taxes$238.8
 $59.0
 $(95.2) $157.8
        
Net income (loss) attributable to our interest in the consolidated T. Rowe Price investment products$113.3
 $30.6
 $(44.2) $88.0
Net income (loss) attributable to redeemable non-controlling interests (unrelated third-party investors)125.5
 28.4
 (51.0) 69.8
 $238.8
 $59.0
 $(95.2) $157.8





Page 29


Three months ended
(in millions)3/31/20213/31/2020
Operating expenses reflected in net operating income$(3.5)$(3.7)
Net investment income (loss) reflected in non-operating income37.2 (330.3)
Impact on income before taxes$33.7 $(334.0)
Net income (loss) attributable to our interest in the consolidated T. Rowe Price investment products$18.3 $(157.5)
Net income (loss) attributable to redeemable non-controlling interests (unrelated third-party investors)15.4 (176.5)
$33.7 $(334.0)
Provision for income taxes

Our effective tax rate for the secondfirst quarter of 2021 was 23.2%, compared with 19.5% in the 2020 and 2019 was 24.8%.quarter. The increase in our effective tax rate for the secondfirst quarter of 2021 as compared to the first quarter of 2020 was impacted by ais primarily due to lower state effectivediscrete tax rate, resulting primarily frombenefits associated with option exercises as well as the remeasurementimpact of deferred tax liabilities relatedthese benefits relative to the firm's investment portfolio,higher pre-tax income in the first quarter of 2021 as compared to the comparable 2020 quarter. These benefits were partially offset by higher net gains attributable to redeemable non-controlling interests held in the firm's consolidated investment products, which are not taxable to the firm despite being included in pre-tax income, and a lower discrete tax benefits associated with option exercises.

Ourstate effective tax rate. The state effective rate forin the six months ended June 30,first quarter of 2020 was 23.9%, compared with 24.7% inunfavorably impacted by the 2019 period. The year-to-date 2020 effectiveremeasurement of deferred state tax rate was lower than the 2019 period primarily dueassets and liabilities related to higher discrete tax benefits associated with option exercises in the 2020 period.our investment portfolio.



Page 25


The following table reconciles the statutory federal income tax rate to our effective tax rate for both the three- and six-three months ended June 30, 2020March 31, 2021 and 2019:2020:

Three months ended Six months endedThree months ended
6/30/2020 6/30/2019 6/30/2020 6/30/20193/31/20213/31/2020
Statutory U.S. federal income tax rate21.0 % 21.0 % 21.0 % 21.0 %Statutory U.S. federal income tax rate21.0 %21.0 %
State income taxes for current year, net of federal income tax benefits(1)
3.7
 4.6
 4.2
 4.4
State income taxes for current year, net of federal income tax benefits(1)
3.8 6.4 
Net (income) losses attributable to redeemable non-controlling interests(.3) (.7) .3
 (.7)Net (income) losses attributable to redeemable non-controlling interests(.6)3.1 
Net excess tax benefits from stock-based compensation plans activity(.4) (.7) (1.7) (.7)Net excess tax benefits from stock-based compensation plans activity(1.2)(8.1)
Other items.8
 .6
 .1
 .7
Other items.2 (2.9)
Effective income tax rate24.8 % 24.8 % 23.9 % 24.7 %Effective income tax rate23.2 %19.5 %
(1) State income tax benefits are reflected in the total benefits for net income attributable to redeemable non-controlling interests and stock-based compensation plans activity.

We currently estimate our effective tax rate for the full-year 2020 will be in the range of 23% to 26%. Our effective tax rate will continue to experience volatility in future periods as the discrete tax benefits recognized from option exercises are impacted by market fluctuations in our stock price and timing of option exercises. The rate will also be impacted by net investment income recognized on our consolidated investment products that are driven by market fluctuations and changes in the proportion of their net income that is attributable to non-controlling interests.

Our non-GAAP effective tax rate for the second quarter of 2020 and 2019 was 24.8% and 25.5%, respectively. Our non-GAAP effective tax rate for the six months ended June 30, 2020 and 2019 was 23.8% and 25.4%, respectively. The non-GAAP tax rate primarily adjusts for the impact of the consolidated investment products, including the significant net lossesincome attributable to the redeemable non-controlling interests. The decrease in theOur non-GAAP effective tax rate isincreased to 23.7% in the first quarter of 2021 compared with 22.5% in first quarter of 2020, primarily due to the lower state effective rate, slightly offset by lower discrete tax benefits associated with option exercises. exercises in the first quarter of 2021 as well as the impact of these benefits relative to the higher pre-tax income in the first quarter of 2021 as compared to the comparable 2020 quarter and a lower effective state tax rate. The firm continues to see the phased-in benefit of the 2018 Maryland state tax legislation in which we expect to reduce our effective state rate over the five-year phase-in period to less than 3% by the end of 2022.

We currently estimate that our non-GAAP effective tax rate for the full-year 2020full year 2021, on a GAAP basis, will be in the range of 22% to 25%. On a non-GAAP basis, the range is 23% to 25%.

NON-GAAP INFORMATION AND RECONCILIATION.

We believe the non-GAAP financial measures below provide relevant and meaningful information to investors about our core operating results. These measures have been established in order to increase transparency for the purpose of evaluating our core business, for comparing current results with prior period results, and to enable more appropriate comparison with industry peers. However, non-GAAP financial measures should not be considered a substitute for financial measures calculated in accordance with U.S. GAAP and may be calculated differently by other companies.



Page 30



The following schedules reconcile certain U.S. GAAP financial measures for the three months ended
March 31, 2021 and 2020.
Three months ended 3/31/2021
Operating expensesNet operating incomeNon-operating income (loss)
Provision (benefit) for income taxes(4)
Net income attributable to T. Rowe Price Group
Diluted earnings per share(5)
U.S. GAAP Basis$933.6 $893.2 $102.1 $230.5 $749.4 $3.17 
Non-GAAP adjustments:
   Consolidated T. Rowe Price
investment products
(1)
(2.2)3.5 (37.2)(3.8)(14.5)(.06)
   Supplemental savings plan liability(2)
(22.2)22.2 (22.1)— .1 — 
   Other non-operating income(3)
— — (29.1)(6.1)(23.0)(.10)
Adjusted Non-GAAP Basis$909.2 $918.9 $13.7 $220.6 $712.0 $3.01 

June 30, 2020 and 2019.

 Three months ended 6/30/2020
 Operating expenses Net operating income Non-operating income (loss) 
Provision (benefit) for income taxes(4)
 Net income attributable to T. Rowe Price Group 
Diluted earnings per share(5)
U.S. GAAP Basis$861.7
 $553.7
 $415.1
 $240.3
 $603.0
 $2.55
Non-GAAP adjustments:           
   Consolidated T. Rowe Price
investment products
(1)
(1.5) 3.6
 (242.4) (54.4) (58.9) (.25)
   Supplemental savings plan liability(2)
(74.4) 74.4
 (64.4) 3.4
 6.6
 .03
   Other non-operating income(3)

 
 (22.5) (11.4) (11.1) (.04)
Adjusted Non-GAAP Basis$785.8
 $631.7
 $85.8
 $177.9
 $539.6
 $2.29

 Three months ended 6/30/2019
 Operating expenses Net operating income Non-operating income (loss) 
Provision (benefit) for income taxes(4)
 Net income attributable to T. Rowe Price Group 
Diluted earnings per share(5)
U.S. GAAP Basis$780.1
 $615.1
 $124.5
 $183.7
 $527.5
 $2.15
Non-GAAP adjustments:           
   Consolidated T. Rowe Price
investment products
(1)
(1.6) 3.8
 (62.8) (9.5) (21.1) (.09)
   Supplemental savings plan liability(2)
(13.9) 13.9
 (12.1) .5
 1.3
 .01
   Other non-operating income(3)

 
 (13.8) (4.2) (9.6) (.04)
Adjusted Non-GAAP Basis$764.6
 $632.8
 $35.8
 $170.5
 $498.1
 $2.03

The following schedules reconcile certain U.S. GAAP financial measures for the six months ended June 30, 2020 and 2019.

 Six months ended 6/30/2020
 Operating expenses Net operating income Non-operating income (loss) 
Provision (benefit) for income taxes(4)
 Net income attributable to T. Rowe Price Group 
Diluted earnings per share(5)
U.S. GAAP Basis$1,617.1
 $1,260.9
 $(85.2) $280.6
 $946.1
 $3.95
Non-GAAP adjustments:           
   Consolidated T. Rowe Price
investment products
(1)
(2.7) 7.3
 87.9
 16.7
 27.5
 .11
   Supplemental savings plan liability(2)
(10.7) 10.7
 4.1
 5.6
 9.2
 .04
   Other non-operating income(3)

 
 17.8
 6.7
 11.1
 .05
Adjusted Non-GAAP Basis$1,603.7
 $1,278.9
 $24.6
 $309.6
 $993.9
 $4.15



Page 3126



Three months ended 3/31/2020
Operating expensesNet operating incomeNon-operating income (loss)
Provision (benefit) for income taxes(4)
Net income attributable to T. Rowe Price Group
Diluted earnings per share(5)
U.S. GAAP Basis$755.4 $707.2 $(500.3)$40.3 $343.1 $1.41 
Non-GAAP adjustments:
   Consolidated T. Rowe Price
investment products
(1)
(1.2)3.7 330.3 71.1 86.4 .36 
   Supplemental savings plan liability(2)
63.7 (63.7)68.5 2.1 2.7 .01 
   Other non-operating income(3)
— — 40.3 18.2 22.1 .09 
Adjusted Non-GAAP Basis$817.9 $647.2 $(61.2)$131.7 $454.3 $1.87 

 Six months ended 6/30/2019
 Operating expenses Net operating income Non-operating income (loss) 
Provision (benefit) for income taxes(4)
 Net income attributable to T. Rowe Price Group 
Diluted earnings per share(5)
U.S. GAAP Basis$1,574.9
 $1,147.6
 $327.3
 $365.0
 $1,040.1
 $4.23
Non-GAAP adjustments:           
   Consolidated T. Rowe Price
investment products
(1)
(3.2) 6.9
 (164.7) (28.4) (59.6) (.24)
   Supplemental savings plan liability(2)
(50.5) 50.5
 (43.1) 2.4
 5.0
 .02
   Other non-operating income(3)

 
 (39.5) (12.7) (26.8) (.11)
Adjusted Non-GAAP Basis$1,521.2
 $1,205.0
 $80.0
 $326.3
 $958.7
 $3.90

(1)
(1)These non-GAAP adjustments remove the impact that the consolidated T. Rowe Price investment products have on our U.S. GAAP consolidated statements of income. Specifically, we add back the operating expenses and subtract the investment income of the consolidated T. Rowe Price investment products. The adjustment to our operating expenses represents the operating expenses of the consolidated products, net of the elimination of related management and administrative fees. The adjustment to net income attributable to T. Rowe Price Group represents the net income of the consolidated products, net of redeemable non-controlling interest. We remove the impact of the consolidated T. Rowe Price investment products. The adjustment to our operating expenses represents the operating expenses of the consolidated products, net of the elimination of related management and administrative fees. The adjustment to net income attributable to T. Rowe Price Group represents the net income of the consolidated products, net of redeemable non-controlling interest. We remove the impact of the consolidated
T. Rowe Price investment products as we believe they impact the reader’s ability to understand our core operating results.

(2)
These non-GAAP adjustments remove the compensation expense impact from market valuation changes in the supplemental savings plan liability and the related net gains (losses) on investments designated as an economic hedge against the related liability. Amounts deferred under the supplemental savings plan are adjusted for appreciation (depreciation) of hypothetical investments chosen by participants. We use T. Rowe Price investment products to economically hedge the exposure to these market movements. We believe it is useful to offset the non-operating investment income (loss) realized on the hedges against the related compensation expense and remove the net impact to help the reader's ability to understand our core operating results and to increase comparability period to period.
(2)    These non-GAAP adjustments remove the compensation expense impact from market valuation changes in the supplemental savings plan liability and the related net gains (losses) on investments designated as an economic hedge against the related liability. Amounts deferred under the supplemental savings plan are adjusted for appreciation (depreciation) of hypothetical investments chosen by participants. We use T. Rowe Price investment products to economically hedge the exposure to these market movements. We believe it is useful to offset the non-operating investment income (loss) realized on the economic hedges against the related compensation expense and remove the net impact to help the reader's ability to understand our core operating results and to increase comparability period to period.

(3)
This non-GAAP adjustment represents the other non-operating income (loss) and the net gains (losses) earned on our non-consolidated investment portfolio that are not designated as economic hedges of the supplemental savings plan liability, and non-consolidated seed investments and other investments that are not part of the cash and discretionary investment portfolio.We retain the investment gains recognized on our non-consolidated cash and discretionary investments as these assets and related income (loss) are considered part of our core operations. We believe adjusting for these non-operating income (loss) items helps the reader’s ability to understand our core operating results and increases comparability to prior years. Additionally, we do not emphasize the impact of the portion of non-operating income (loss) removed when managing and evaluating our core performance.
(3)    This non-GAAP adjustment represents the other non-operating income (loss) and the net gains (losses) earned on our non-consolidated investment portfolio that are not designated as economic hedges of the supplemental savings plan liability, and non-consolidated seed investments and other investments that are not part of the cash and discretionary investment portfolio.We retain the investment gains recognized on our non-consolidated cash and discretionary investments as these assets and related income (loss) are considered part of our core operations. We believe adjusting for these non-operating income (loss) items helps the reader’s ability to understand our core operating results and increases comparability to prior years. Additionally, we do not emphasize the impact of the portion of non-operating income (loss) removed when managing and evaluating our core performance.

(4)
The income tax impacts were calculated in order to achieve an overall non-GAAP effective tax rate of 23.8% for the first half of 2020 and 25.4% for the first half of 2019. As such, the non-GAAP effective tax rate for the second quarter was 24.8% for 2020 and 25.5% for 2019. We estimate that our effective tax rate for the full-year 2020 on a non-GAAP basis will be in the range of 23% to 25%.
(4)    The income tax impacts were calculated in order to achieve an overall non-GAAP effective tax rate of 23.7% for 2021 and 22.5% for 2020. We estimate that our effective tax rate for the full-year 2021 on a non-GAAP basis will be in the range of 23% to 25%.

(5)
This non-GAAP measure was calculated by applying the two-class method to adjusted net income attributable to T. Rowe Price Group divided by the weighted-average common shares outstanding assuming dilution. The calculation of adjusted net income allocated to common stockholders is as follows:

(5)    This non-GAAP measure was calculated by applying the two-class method to adjusted net income attributable to T. Rowe Price Group divided by the weighted-average common shares outstanding assuming dilution. The calculation of adjusted net income allocated to common stockholders is as follows:
Three months ended
3/31/20213/31/2020
Adjusted net income attributable to T. Rowe Price Group$712.0 $454.3 
Less: adjusted net income allocated to outstanding restricted stock and stock unit holders18.9 12.4 
Adjusted net income allocated to common stockholders$693.1 $441.9 
  Three months ended Six months ended
  6/30/20206/30/2019 6/30/2020
6/30/2019
Adjusted net income attributable to T. Rowe Price Group $539.6
$498.1
 $993.9
$958.7
Less: adjusted net income allocated to outstanding restricted stock and stock unit holders 15.0
12.8
 27.4
24.4
Adjusted net income allocated to common stockholders $524.6
$485.3
 $966.5
$934.3


Page 3227



CAPITAL RESOURCES AND LIQUIDITY.

Sources of Liquidity
We remain debt-free with ample liquidity, including cash and investments in T. Rowe Price products, as follows:
(in millions)3/31/202112/31/2020
Cash and cash equivalents$2,830.1 $2,151.7 
Discretionary investments2,019.2 2,095.7 
Total cash and discretionary investments4,849.3 4,247.4 
Redeemable seed capital investments1,244.3 1,219.1 
Investments used to hedge the supplemental savings plan liability766.9 768.1 
Total cash and investments in T. Rowe Price products$6,860.5 $6,234.6 
(in millions) 6/30/2020 12/31/2019
Cash and cash equivalents $2,058.1
 $1,781.8
Discretionary investments 2,021.9
 1,899.6
Total cash and discretionary investments 4,080.0
 3,681.4
Redeemable seed capital investments 1,074.2
 1,325.6
Investments used to hedge the supplemental savings plan liability 564.5
 561.1
Total cash and investments in T. Rowe Price products $5,718.7
 $5,568.1

Our discretionary investment portfolio is comprised primarily of short duration bond funds, which typically yield higher than money market rates, and asset allocation products. Cash and discretionary investments returned gains of $85.8 million and $24.6$13.7 million in the three- and six-three months ended June 30, 2020, respectively,March 31, 2021, as compared to generating incomeinvestment losses of $35.8 million and $80.0$61.2 million in the three- and six-three months ended June 30, 2019.March 31, 2020. Cash and discretionary investments in T. Rowe Price products held by our subsidiaries outside the U.S.United States were $720.5$754.4 million at June 30, 2020March 31, 2021 and $665.8$675.8 million at December 31, 2019.2020. Given the availability of our financial resources and cash expected to be generated through future operations, we do not maintain an available external source of additional liquidity.

Our seed capital investments are redeemable, although we generally expect to be invested for several years for the products to build an investment performance history and until unrelated third-party investors substantially reduce our relative ownership percentage.

The cash and investment presentation on the unaudited condensed consolidated balance sheet is based on the accounting treatment for the cash equivalent or investment item. The following table details how T. Rowe Price Group’s interests in cash and investments relate to where they are presented on the unaudited condensed consolidated balance sheet as of June 30, 2020.March 31, 2021.
(in millions)Cash and cash equivalentsInvestments
Net assets of consolidated T. Rowe Price investment products(1)
3/31/2021
Cash and discretionary investments$2,830.1 $1,910.1 $109.1 $4,849.3 
Seed capital investments— 473.2 771.1 1,244.3 
Investments used to hedge the supplemental savings plan liability— 766.9 — 766.9 
Total cash and investments in T. Rowe Price products attributable to T. Rowe Price Group2,830.1 3,150.2 880.2 6,860.5 
Investment in UTI and other investments— 253.4 — 253.4 
Total cash and investments attributable to T. Rowe Price Group2,830.1 3,403.6 880.2 7,113.9 
Redeemable non-controlling interests— — 1,012.9 1,012.9 
As reported on unaudited condensed consolidated balance sheet at March 31, 2021$2,830.1 $3,403.6 $1,893.1 $8,126.8 
(in millions) Cash and cash equivalents Investments 
Net assets of consolidated T. Rowe Price investment products(1)
 6/30/2020
Cash and discretionary investments $2,058.1
 $1,802.0
 $219.9
 $4,080.0
Seed capital investments 
 277.5
 796.7
 1,074.2
Investments used to hedge the supplemental savings plan liability 
 564.5
 
 564.5
Total cash and investments in T. Rowe Price products attributable to T. Rowe Price Group 2,058.1
 2,644.0
 1,016.6
 5,718.7
Investment in UTI and other investments 
 256.0
 
 256.0
Total cash and investments attributable to T. Rowe Price Group 2,058.1
 2,900.0
 1,016.6
 5,974.7
Redeemable non-controlling interests 
 
 1,090.1
 1,090.1
As reported on unaudited condensed consolidated balance sheet at June 30, 2020 $2,058.1
 $2,900.0
 $2,106.7
 $7,064.8
(1) The consolidated T. Rowe Price investment products are generally those products we provided seed capital at the time of their formation and we have a controlling interest. These products generally represent U.S. mutual funds as well as those funds regulated outside the U.S.     The $109.1 million and the $771.1 million represent the total value at March 31, 2021 of our interest in the consolidated T. Rowe Price investment products. The total net assets of the T. Rowe Price investment products at March 31, 2021 of $1,893.1 million includes assets of $1,946.8 million, less liabilities of $53.7 million as reflected in our unaudited condensed consolidated balance sheets.

(1)
The T. Rowe Price investment products that we consolidate are generally those products we provided seed capital at the time of their formation and we have a controlling interest. These products generally represent U.S. mutual funds as well as those funds regulated outside the U.S. The net assets of the T. Rowe Price investment products at June 30, 2020 consist of product assets we consolidate on our unaudited condensed consolidated balance sheets of $2,161.5 million, less the liabilities of these products of $54.8 million.

Our unaudited condensed consolidated balance sheet reflects the cash and cash equivalents, investments, other assets and liabilities of those T. Rowe Price investment products we consolidate, as well as redeemable non-controlling interests for the portion of these T. Rowe Price investment products that are held by unrelated third-party investors. Although we can redeem our net interest in these T. Rowe Price investment products at any time, we


Page 3328



cannot directly access or sell the assets held by the products to obtain cash for general operations. Additionally, the assets of these T. Rowe Price investment products are not available to our general creditors. Our interest in these
T. Rowe Price investment products was used as initial seed capital and is recategorized as discretionary when it is determined by management that the seed capital is no longer needed. We assess the discretionary investment products and, when we decide to liquidate our interest, we seek to do so in a way as to not impact the product and, ultimately, the unrelated third-party investors.

Uses of Liquidity

We increased our quarterly recurring dividend per common share in February 20202021 by 18.4%20.0% to $.90$1.08 per common share from $.76$.90 per common share. Additionally, we expended $1,028.7 million$.3 billion in the first halfquarter of 20202021 to repurchase 9.61.6 million shares, or 4.1%0.7%, of our outstanding common stock at an average price of $106.43$164.22 per share. These dividends and repurchases were expended using existing cash balances and cash generated from operations. While opportunistic in our approach to stock buybacks, we will generally repurchase our common stock over time to offset the dilution created by our equity-based compensation plans.

Since the end of 2017,2018, we have returned $4.7$4.0 billion to stockholders through stock repurchases and our regular quarterly dividends, as follows:
(in millions)Recurring dividendStock repurchasesTotal cash returned to stockholders
2019$733.6 $708.8 $1,442.4 
2020846.0 1,192.2 2,038.2 
Three months ended 3/31/2021252.3 267.6 519.9 
Total$1,831.9 $2,168.6 $4,000.5 
(in millions)Recurring dividend Stock repurchases Total cash returned to stockholders
2018$694.7
 $1,099.6
 $1,794.3
2019733.6
 708.8
 1,442.4
Six months ended 6/30/2020425.1
 1,028.8
 1,453.9
Total$1,853.4
 $2,837.2
 $4,690.6

We anticipate property, equipment and equipmentother capital expenditures, including internal labor capitalization, for the full-year 20202021 to be about $225$265 million, of which more than three-quarters is planned for technology initiatives. We expect to fund our anticipated capital expenditures with operating cash flows and other available resources.


Page 3429




Cash Flows

The following table summarizes the cash flows for the sixthree months ended June 30,March 31, 2021 and 2020, and 2019, that are attributable to T. Rowe Price Group, our consolidated T. Rowe Price investment products, and the related eliminations required in preparing the statement.
 Six months ended
 6/30/2020 6/30/2019
(in millions)Cash flow attributable to T. Rowe Price Group Cash flow attributable to consolidated T. Rowe Price investment products Elims As reported Cash flow attributable to T. Rowe Price Group Cash flow attributable to consolidated T. Rowe Price investment products Elims As reported
Cash flows from operating activities               
Net income$946.1
 $(95.2) $44.2
 $895.1
 $1,040.1
 $157.8
 $(88.0) $1,109.9
Adjustments to reconcile net income to net cash provided by operating activities               
Depreciation and amortization of property and equipment94.3
 
 
 94.3
 86.0
 
 
 86.0
Stock-based compensation expense111.6
 
 
 111.6
 90.7
 
 
 90.7
Net (gains) losses recognized on investments47.6
 
 (44.2) 3.4
 (212.4) 
 88.0
 (124.4)
Net investments in T. Rowe Price investment products used to economically hedge supplemental savings plan liability(10.0) 
 
 (10.0) (19.3) 
 
 (19.3)
Net change in trading securities held by consolidated T. Rowe Price investment products
 40.8
 
 40.8
 
 (444.0) 
 (444.0)
Other changes in assets and liabilities501.1
 5.4
 (1.0) 505.5
 257.9
 (4.9) (3.1) 249.9
Net cash provided by (used in) operating activities1,690.7
 (49.0) (1.0) 1,640.7
 1,243.0
 (291.1) (3.1) 948.8
Net cash provided by (used in) investing activities(15.6) (9.2) 27.2
 2.4
 (174.0) (5.1) 150.0
 (29.1)
Net cash provided by (used in) financing activities(1,398.8) 113.9
 (26.2) (1,311.1) (691.8) 337.2
 (146.9) (501.5)
Effect of exchange rate changes on cash and cash equivalents of consolidated T. Rowe Price investment products
 (7.4) 
 (7.4) 
 (.4) 
 (.4)
Net change in cash and cash equivalents during period276.3
 48.3
 
 324.6
 377.2
 40.6
 
 417.8
Cash and cash equivalents at beginning of year1,781.8
 76.5
 
 1,858.3
 1,425.2
 70.1
 
 1,495.3
Cash and cash equivalents at end of period$2,058.1
 $124.8
 $
 $2,182.9
 $1,802.4
 $110.7
 $
 $1,913.1

Three months ended
3/31/20213/31/2020
(in millions)Cash flow attributable to T. Rowe Price GroupCash flow attributable to consolidated T. Rowe Price investment productsElimsAs reportedCash flow attributable to T. Rowe Price GroupCash flow attributable to consolidated T. Rowe Price investment productsElimsAs reported
Cash flows from operating activities
Net income$749.4 $33.7 $(18.3)$764.8 $343.1 $(334.0)$157.5 $166.6 
Adjustments to reconcile net income to net cash provided by operating activities
Depreciation and amortization of property and equipment49.0 — — 49.0 46.1 — — 46.1 
Stock-based compensation expense57.5 — — 57.5 58.3 — — 58.3 
Net (gains) losses recognized on investments(77.8)— 18.3 (59.5)324.8 — (157.5)167.3 
Net change in T. Rowe Price investment products used to economically hedge supplemental savings plan liability22.0 — — 22.0 (8.9)— — (8.9)
Net change in trading securities held by consolidated T. Rowe Price investment products— (120.9)— (120.9)— 234.6 — 234.6 
Other changes in assets and liabilities338.5 (56.5)(.2)281.8 100.6 23.7 (.6)123.7 
Net cash provided by (used in) operating activities1,138.6 (143.7)(.2)994.7 864.0 (75.7)(.6)787.7 
Net cash provided by (used in) investing activities30.4 (27.3)(33.9)(30.8)(15.0)(.8)43.4 27.6 
Net cash provided by (used in) financing activities(490.6)149.0 34.1 (307.5)(1,068.4)118.9 (42.8)(992.3)
Effect of exchange rate changes on cash and cash equivalents of consolidated T. Rowe Price investment products— .9 — .9 — (1.2)— (1.2)
Net change in cash and cash equivalents during period678.4 (21.1)— 657.3 (219.4)41.2 — (178.2)
Cash and cash equivalents at beginning of year2,151.7 104.8 — 2,256.5 1,781.8 76.5 — 1,858.3 
Cash and cash equivalents at end of period$2,830.1 $83.7 $— $2,913.8 $1,562.4 $117.7 $— $1,680.1 

Page 3530




Operating Activities
Operating activities attributable to T. Rowe Price Group during the first halfquarter of 20202021 provided cash flows of $1,690.7$1,138.6 million as compared to $1,243.0$864.0 million during the first halfquarter of 2019.2020. Operating cash flows attributable to T. Rowe Price Group increased $447.7$274.6 million, as $298.5including a $406.3 million in higher non-cash adjustments, including unrealized investment gains/losses, depreciation, and stock-based compensation expense, more than offset the $94.0 million declineincrease in net income from the first half of 2019. The non-cash adjustments were driven by a $260.0 million change in net investment gains/losses as we recognized overall investment losses in the first halfquarter of 2020 compared with gains in the first half of 2019. The overall investment losses in 2020, which are added back to net income, were a result of the market disruption caused by the coronavirus pandemic in 2020. Additionally,and timing differences on the cash settlement of our assets and liabilities decreased cash flowsof $237.9 million. These increases were partially offset by $243.2 million.$400.5 million in lower non-cash adjustments, including unrealized investment gains/losses, depreciation, and stock-based compensation expense. The non-cash adjustments were primarily driven by a $402.6 million increase in net investment gains in the first quarter of 2021 compared with net investment losses in the first quarter of 2020. Additionally, in 2021, we had net proceeds of $22.0 million from certain investment products that economically hedge our supplemental savings plan liability, while we had net investments of $8.9 million in the same period of 2020. Our interim operating cash flows do not include the cash impact of variable compensation that is accrued throughout the year before being substantially paid out in December. The remaining change in reported cash flows from operating activities was attributable to the net change in trading securities held in our consolidated investment products’ underlying portfolios.

Investing Activities
Net cash used inprovided by investing activities that are attributable to T. Rowe Price Group totaled $15.6$30.4 million in the first halfquarter of 20202021 compared with $174.0$15.0 million of cash used by investing activities in the 20192020 period. During 2020,2021, we receiveddecreased the level of seed capital provided by $77.3 million. We eliminate our seed capital in those T. Rowe Price investment products we consolidate in preparing our unaudited condensed consolidated statement of cash flows. Partially offsetting this increase to cash provided by investing activities were lower net proceeds from the sale of certain of our discretionary investments of $110.8$47.8 million compared to net proceeds of $68.9$74.0 million during 2019.2020. In addition, while we increased our property and equipment expenditures by $10.8 million, we decreased the level of seed capital provided by $122.8$12.8 million. Since we consolidate the seed capital in T. Rowe Price investment products, our seed capital was eliminated in preparing our unaudited condensed consolidated statement of cash flows. The remaining $4.1$26.5 million change in reported cash flows from investing activities is related to the net cash removed from our balance sheet from consolidating and deconsolidating investment products.

Financing Activities
Net cash used in financing activities attributable to T. Rowe Price Group were $1,398.8$490.6 million in the first halfquarter of 20202021 compared with $691.8$1,068.4 million in the 20192020 period. During 2020,2021, there was a $624.3$632.1 million increasedecrease in cash paid for common stock repurchases as we repurchased 5.56.7 million moreless shares of common stock in the first halfquarter of 20202021 as compared to the first halfquarter of 2019. Additionally, there2020. Partially offsetting this decrease in cash used for financing activities was a $57.9$37.1 million increase in dividends paid in 20202021 as a result of an 18.4%20.0% increase in our quarterly dividend per share. The remaining change in reported cash flows from financing activities is primarily attributable to a $102.6$107.0 million decreaseincrease in net subscriptions received from redeemable non-controlling interest holders of our consolidated investment products during the first halfquarter of 20202021 compared to the 20192020 period.

CRITICAL ACCOUNTING POLICIES.

The preparation of financial statements often requires the selection of specific accounting methods and policies from among several acceptable alternatives. Further, significant estimates and judgments may be required in selecting and applying those methods and policies in the recognition of the assets and liabilities in our unaudited condensed consolidated balance sheets, the revenues and expenses in our unaudited condensed consolidated statements of income, and the information that is contained in our significant accounting policies and notes to unaudited condensed consolidated financial statements. Making these estimates and judgments requires the analysis of information concerning events that may not yet be complete and of facts and circumstances that may change over time. Accordingly, actual amounts or future results can differ materially from those estimates that we include currently in our unaudited condensed consolidated financial statements, significant accounting policies, and notes.

There have been no material changes in the critical accounting policies previously identified in our 20192020 Annual Report on Form 10-K.

NEWLY-ISSUED BUT NOT YET ADOPTED ACCOUNTING GUIDANCE.

See Note 1 - The Company and Basis of Preparation note within Item 1. Financial Statements for a discussion of newly issued but not yet adopted accounting guidance.



Page 3631



FORWARD-LOOKING INFORMATION.

From time to time, information or statements provided by or on behalf of T. Rowe Price, including those within this report, may contain certain forward-looking information, including information or anticipated information relating to: our revenues, net income, and earnings per share on common stock; changes in the amount and composition of our assets under management; our expense levels; our tax rate; and our expectations regarding financial markets, future transactions, dividends, stock repurchases, investments, new products and services, capital expenditures, changes in our effective fee rate, the impact of the coronavirus pandemic, and other market conditions. Readers are cautioned that any forward-looking information provided by or on behalf of T. Rowe Price is not a guarantee of future performance. Actual results may differ materially from those in forward-looking information because of various factors including, but not limited to, those discussed below and in Item 1A, Risk Factors, of this Form 10-Q andincluded in our Form 10-K Annual Report for 2019.2020. Further, forward-looking statements speak only as of the date on which they are made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which it is made or to reflect the occurrence of unanticipated events.

Our future revenues and results of operations will fluctuate primarily due to changes in the total value and composition of assets under our management. Such changes result from many factors, including, among other things: cash inflows and outflows in the U.S. mutual funds, and subadvised andfunds, separately managed fundsaccounts, collective investment trusts, and other investment products, fluctuations in global financial markets that result in appreciation or depreciation of the assets under our management, our introduction of new mutual funds and investment products, changes in retirement savings trends relative to participant-directed investments and defined contribution plans, and the impact of the recent coronavirus outbreak. The ability to attract and retain investors’ assets under our management is dependent on investor sentiment and confidence; the relative investment performance of the U.S. mutual funds and other managed investment products as compared with competing offerings and market indexes; the ability to maintain our investment management and administrative fees at appropriate levels; competitive conditions in the mutual fund, asset management, and broader financial services sectors; and our level of success in implementing our strategy to expand our business.business, including our announced plan to establish T. Rowe Price Investment Management as a separate registered investment adviser. Our revenues are substantially dependent on fees earned under contracts with the T. Rowe Price funds and could be adversely affected if the independent directors of one or more of the T. Rowe Price funds terminated or significantly altered the terms of the investment management or related administrative services agreements. Non-operating investment income will also fluctuate primarily due to the size of our investments, changes in their market valuations, and any other-than-temporary impairments that may arise or, in the case of our equity method investments, our proportionate share of the investees' net income.

Our future results are also dependent upon the level of our expenses, which are subject to fluctuation for the following or other reasons: changes in the level of our advertising and promotion expenses in response to market conditions, including our efforts to expand our investment advisory business to investors outside the U.S. and to further penetrate our distribution channels within the U.S.; the pace and level of spending to support key strategic priorities; variations in the level of total compensation expense due to, among other things, bonuses, restricted stock units and other equity grants, other incentive awards, our supplemental savings plan, changes in our employee count and mix, and competitive factors; any goodwill or other asset impairment that may arise; fluctuation in foreign currency exchange rates applicable to the costs of our international operations; expenses and capital costs, such as technology assets, depreciation, amortization, and research and development, incurred to maintain and enhance our administrative and operating services infrastructure; the timinglevel of the assumption of all third party research payments,costs, unanticipated costs that may be incurred to protect investor accounts and the goodwill of our clients; and disruptions of services, including those provided by third parties, such as fund and product recordkeeping, facilities, communications, power, and the mutual fund transfer agent and accounting systems.

Our business is also subject to substantial governmental regulation, and changes in legal, regulatory, accounting, tax, and compliance requirements may have a substantial effect on our operations and results, including, but not limited to, effects on costs that we incur and effects on investor interest in T. Rowe Price investment products and investing in general or in particular classes of mutual funds or other investments.






Page 3732



Item 3.Quantitative and Qualitative Disclosures About Market Risk.

Item 3.Quantitative and Qualitative Disclosures About Market Risk.
EQUITY PRICE RISK.

DuringThere has been no material change in the first quarter of 2020, the impacttotal potential loss information provided in Item 7A of the global coronavirus pandemic began to rapidly spread throughout the world and caused increasing disruption to populations, economic activity, and the global financial markets. While markets recovered sharply in the second quarter of 2020, the impact and ongoing uncertainty related to the pandemic continued into the end of JuneForm 10-K Annual Report for 2020. Since our investments in T. Rowe Price investment products are carried at fair value, these investments are subject to market risk. The following table presents the equity price risk from our investments in T. Rowe Price investment products. Investments in these products generally moderate market risk as they are diversified and invest in a number of different financial instruments. T. Rowe Price manages its cash and discretionary investments exposure to market risk by diversifying its investments among equity and fixed income portfolios. In addition, investment holdings may be altered from time to time in response to changes in market risks and other factors, as management deems appropriate. We do not actively manage the market risk related to our our seed capital investments.

In order to quantify the sensitivity of our investments to changes in market valuations, we have chosen to use a variant of each product's net asset value to quantify the equity price risk, as we believe the volatility in each product's net asset value best reflects the underlying risk potential as well as the market trends surrounding each of its investment objectives. The potential future loss of value, before any income tax benefits, of these investments at June 30, 2020 was determined by using the lower of each product’s lowest net asset value per share during the first half of 2020 or its net asset value per share at June 30, 2020, reduced by 10%. In considering this presentation, it is important to note that: not all products experienced their lowest net asset value per share on the same day; it is likely that the composition of the investment portfolio would be changed if adverse market conditions persisted; and we could experience future losses in excess of those presented below.

(in millions)Fair value 6/30/2020 Potential lower value Potential
loss
Investments in T. Rowe Price products       
Discretionary investments$992.4
 $892.9
 $99.5
 10%
Seed capital not consolidated132.2
 55.5
 76.7
 58%
Investments designated as an economic hedge of supplemental savings plan liability held at fair value529.2
 410.2
 119.0
 22%
Total$1,653.8
 $1,358.6
 $295.2
 18%
Direct investment in consolidated T. Rowe Price investment products       
Discretionary investments$219.9
 $169.0
 $50.9
 23%
Seed capital796.7
 669.8
 126.9
 16%
Total$1,016.6
 $838.8
 $177.8
 17%
Investment partnerships and other investments held at fair value$93.4
 $82.5
 $10.9
 12%

Any losses arising from the change in fair value of investments in T. Rowe Price products would result in a corresponding decrease, net of tax, in our net income attributable to T. Rowe Price Group.

The direct investment in consolidated T. Rowe Price investment products represents our portion of the net assets of the product. Upon consolidation of these products, our direct investment is eliminated, and the net assets of the products are combined in our consolidated balance sheet, together with redeemable non-controlling interests, which represents the portion of the products that is owned by unrelated third-party investors. Any losses arising from the change in fair value of our direct investments in consolidated T. Rowe Price investment products would also result in a corresponding decrease, net of tax, in our net income attributable to T. Rowe Price Group.

Further, we have investments that are used to economically hedge the change in our supplemental savings plan liability. Since we are hedging the liability, the impact on our net income attributable to T. Rowe Price Group would result from any ineffectiveness of this economic hedge.



Page 38



Item 4.Controls and Procedures.

Item 4.Controls and Procedures.

Our management, including our principal executive and principal financial officers, has evaluated the effectiveness of our disclosure controls and procedures as of June 30, 2020.March 31, 2021. Based on that evaluation, our principal executive and principal financial officers have concluded that our disclosure controls and procedures as of June 30, 2020,March 31, 2021, are effective at the reasonable assurance level to ensure that the information required to be disclosed by us in the reports that we file or submit under the Securities Exchange Act of 1934, including this Form 10-Q quarterly report, is recorded, processed, summarized, and reported, within the time periods specified in the Securities and Exchange Commission’s rules and forms, and to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.


Our management, including our principal executive and principal financial officers, has evaluated any change in our internal control over financial reporting that occurred during the secondfirst quarter of 2020,2021, and has concluded that there was no change during the secondfirst quarter of 20202021 that hashave materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.


PART II – OTHER INFORMATION
 
Item 1. Legal Proceedings.

On February 14, 2017, T. Rowe Price Group, Inc., T. Rowe Price Associates, Inc., T. Rowe Price Trust Company, currentFor information about our legal proceedings, please see our Commitments and former membersContingencies footnote to our unaudited condensed consolidated financial statements in Part 1. of the management committee, and trustees of the T. Rowe Price U.S. Retirement Program were named as defendants in a lawsuit filed in the United States District Court for the District of Maryland. The lawsuit alleges breaches of ERISA’s fiduciary duty and prohibited transaction provisions on behalf of a class of all participants and beneficiaries of the T. Rowe Price 401(k) Plan from February 14, 2011, to the time of judgment. The matter has been certified as a class action. T. Rowe Price believes the claims are without merit and is vigorously defending the action. This matter is in the expert discovery phase of litigation and we cannot predict the eventual outcome, or whether it will have a material negative impact on our financial results, or estimate the possible loss or range of loss that may arise from any negative outcome.this Form 10-Q.

On April 27, 2016, certain shareholders in the T. Rowe Price Blue Chip Growth Fund, T. Rowe Price Capital Appreciation Fund, T. Rowe Price Equity Income Fund, T. Rowe Price Growth Stock Fund, T. Rowe Price International Stock Fund, T. Rowe Price High Yield Fund, T. Rowe Price New Income Fund and T. Rowe Price Small Cap Stock Fund (the “Funds”) filed a Section 36(b) complaint under the caption Zoidis v. T. Rowe Price Assoc., Inc., against T. Rowe Price Associates, Inc. (“T. Rowe Price”) in the United States District Court for the Northern District of California. The complaint alleges that the management fees for the identified funds are excessive because
T. Rowe Price charges lower advisory fees to subadvised clients with funds in the same strategy. The complaint seeks to recover the allegedly excessive advisory fees received by T. Rowe Price in the year preceding the start of the lawsuit, along with investments’ returns and profits. In the alternative, the complaint seeks the rescission of each fund’s investment management agreement and restitution of any allegedly excessive management fees.
T. Rowe Price believes the claims are without merit and is vigorously defending the action. This matter is in the discovery phase of litigation and we cannot predict the eventual outcome, or whether it will have a material negative impact on our financial results, or estimate the possible loss or range of loss that may arise from any negative outcome.

In addition to the matters discussed above, various claims against us arise in the ordinary course of business, including employment-related claims. In the opinion of management, after consultation with counsel, the likelihood of an adverse determination in one or more of these pending ordinary course of business claims that would have a material adverse effect on our financial position or results of operations is remote.

Item 1A. Risk Factors.

Information regarding our risk factors appears in Item 1A. of our Annual Report on Form 10-K for the fiscal year ended December 31, 2019 filed with the SEC on February 13, 2020. The following risk factor has occurred since previously reporting our risk factors in Item 1A. of our Annual Report on Form 10-K for the fiscal year ended December 31, 2019.


Page 39


Our business, financial condition, and results of operation may be adversely affected by the recent coronavirus outbreak.
Beginning in early 2020, global financial marketsThere have been monitoring and reacting to the novel coronavirus pandemic. The spread of the coronavirus has created significant volatility, uncertainty and economic disruption to the global economy and may impact our business, financial condition and results of operations. In particular global financial markets have seen increased volatility and significantno material changes in the value of investments. If the valueinformation provided in Item 1A of our Form 10-K Annual Report for 2020.
assets under our management decreases, our revenue and operating results could be materially impacted. Furthermore, while we have in place robust and well-established business continuity plans that address the potential impact to our associates and our facilities, and a comprehensive suite of technologies which enable our associates to work remotely and conduct business, no assurance can be given that the steps we have taken will continue to be effective or appropriate. In the event that our associates become incapacitated by the coronavirus, our business operations may be impacted, which could lead to reputational and financial harm. Since our revenue is based on the market value and composition of the assets under our management, the ultimate impact on global financial markets and our clients’ decisions related to this event could adversely affect the Company’s revenue and operating results.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

(c) Repurchase activity during the secondfirst quarter of 20202021 is as follows:
 
Month 
Total Number of
Shares Purchased
 
Average Price
Paid per Share
 
Total Number of
Shares Purchased as
Part of Publicly
Announced Program
 Maximum Number of Shares that May Yet Be Purchased Under the Program
April 455,998
 $96.22
 439,158
 23,601,902
May 422,044
 $109.57
 386,324
 23,215,578
June 512,617
 $120.74
 479,414
 22,736,164
Total 1,390,659
 $109.31
 1,304,896
  

Month
Total Number of
Shares Purchased
Average Price
Paid per Share
Total Number of
Shares Purchased as
Part of Publicly
Announced Program
Maximum Number of Shares that May Yet Be Purchased Under the Program
January178,193 $151.29 142,551 21,324,760 
February864,525 $161.23 799,129 20,525,631 
March715,743 $170.76 687,784 19,837,847 
Total1,758,461 $164.10 1,629,464 

Shares repurchased by us in a quarter may include repurchases conducted pursuant to publicly announced board authorization, outstanding shares surrendered to the company to pay the exercise price in connection with swap exercises of employee stock options, and shares withheld to cover the minimum tax withholding obligation associated with the vesting of restricted stock awards. Of the total number of shares purchased during the secondfirst quarter of 2020, 85,7632021, 128,997 were related to shares surrendered in connection with employee stock option exercises and no shares were withheld to cover tax withholdings associated with the vesting of restricted stock awards.



Page 33


The following table details the changes in and status of the Board of Directors’ outstanding publicly announced board authorizations.
Authorization Dates1/1/2021Total Number of
Shares Purchased
Maximum Number of Shares that May Yet Be Purchased at 3/31/2021
February 20196,467,311 (1,629,464)4,837,847 
March 202015,000,000 — 15,000,000 
21,467,311 (1,629,464)19,837,847 

Authorization Dates 4/1/2020 Total Number of
Shares Purchased
 Maximum Number of Shares that May Yet Be Purchased at 6/30/2020
February 2019 9,041,060
 (1,304,896) 7,736,164
March 2020 15,000,000
 
 15,000,000
  24,041,060
 (1,304,896) 22,736,164

Item 4. Mine Safety Disclosures.

Not applicable.

Item 5.Other Information.


On JulyApril 29, 2020,2021, we issued an earnings release reporting our results of operations for the secondfirst quarter of 2020 and the first six months of 2020.2021. A copy of that earnings release is furnished herewith as Exhibit 99.199.1. This information shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933.



Page 40




Item 6. Exhibits.

The following exhibits required by Item 601 of Regulation S-K are furnished herewith.
3(i)
3(ii)
10.115
15
31(i).1
31(i).2
32
99.1
101The following series of unaudited XBRL-formatted documents are collectively included herewith as Exhibit 101. The financial information is extracted from T. Rowe Price Group’s unaudited condensed consolidated interim financial statements and notes that are included in this Form 10-Q Report.
101.INSXBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCHXBRL Taxonomy Extension Schema Document
101.CALXBRL Taxonomy Calculation Linkbase Document
101.LABXBRL Taxonomy Label Linkbase Document
101.PREXBRL Taxonomy Presentation Linkbase Document
101.DEFXBRL Taxonomy Definition Linkbase Document



Page 4134




SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized on JulyApril 29, 2020.2021.
T. Rowe Price Group, Inc.

By:    /s//s/ Céline S. Dufétel
Vice President, Chief Operating Officer, Chief Financial Officer and Treasurer


Page 4235